Page last updated: 2024-08-23

atomoxetine hydrochloride and methylphenidate

atomoxetine hydrochloride has been researched along with methylphenidate in 405 studies

Research

Studies (405)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (0.25)	18.2507
2000's	104 (25.68)	29.6817
2010's	243 (60.00)	24.3611
2020's	57 (14.07)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Biederman, J; Faraone, SV; Spencer, T; Wilens, TE	1
Badger, GJ; Bickel, WK; Faries, DE; Heil, SH; Higgins, ST; Holmes, HW; Laws, HF	1
Biederman, J; Casat, C; Dittmann, R; Heiligenstein, JH; Kratochvil, CJ; Michelson, D; Milton, D; Newcorn, JH; Spencer, TJ; Wernicke, J	1
Carrey, N; Khan, SC; Kusumakar, V; MacMaster, FP; Sparkes, SJ	1
Daley, KC	1
Arneric, SP; Bain, JN; Buccafusco, JJ; Prendergast, MA; Smith, MA; Terry, AV	1
Le Heuzey, MF	2
Biederman, J; Spencer, T; Wilens, T	1
Artigas Pallares, J	1
Reeves, G; Schweitzer, J	1
Wee, S; Woolverton, WL	1
Bergman, J; Gasior, M; Kallman, MJ; Paronis, CA	1
Feinberg, DT; McGough, JJ; Pataki, CS	1
Hazell, P	1
Dodson, WW	1
Hamilton, J	1
Amler, RW; Brown, RT; Feldman, HM; Freeman, WS; Perrin, JM; Pierce, K; Stein, MT; Wolraich, ML	1
Kelly, RP; Lowe, S; Read, HA; Smith, BP; Soon, D; Teng, CH; Wise, SD; Yeo, KP	1
Gilbert, DL; Lipps, TD; Ridel, KR; Sallee, FR; Wassermann, EM; Zhang, J	1
Dougherty, M; McDonnell, MA	1
Battel, S; Dittmann, RW; Döpfner, M; Lehmkuhl, G; Sevecke, K	1
Pritchard, D	2
Bymaster, FP; Davis, RJ; McKinzie, DL; Nomikos, GG; Overshiner, CD; Perry, KW; Tzavara, ET; Witkin, JM; Wolff, M	1
Owens, JA; Sangal, J; Sangal, RB	1
Prince, JB	1
Kemner, J; Starr, HL	1
Karande, S	1
Robertson, MM	1
Lechner, E; Schonwald, A	1
Greenfield, B; Slatkoff, J	1
Durell, TM; Glaser, PE; Lile, JA; Rush, CR; Stoops, WW	1
Badreldin, N; Gilbert, DL; Lipps, TD; Merhar, S; Ridel, KR; Sallee, FR; Wang, Z; Wassermann, EM; White, C; Zhang, J	1
Benarroch, F; Gross-Tsur, V; Jaworowski, S	1
Asseburg, C; Drummond, M; Golder, S; Griffin, S; Hodges, Z; King, S; Richardson, G; Riemsma, R; Taylor, E; Weatherly, H	1
Sangal, JM; Sangal, RB	1
Unni, JC	1
Acharya, N; Allen, AJ; Bangs, ME; Dellva, MA; Polzer, J; Tauscher-Wisniewski, S; Watson, SB; Wilens, TE; Zhang, S	1
Easton, N; Fone, K; Marsden, C; Marshall, F; Steward, C	1
Blondeau, C; Dellu-Hagedorn, F	1
Connolly, M; Dunn, DW; Gonzalez-Heydrich, J; Jan, JE; Kratochvil, CJ; Plioplys, S; Wambera, K; Weiss, M	1
Horner, WE; Johnson, DE; Rollema, H; Schmidt, AW	1
Langsetmo, HK; Reimers, A	1
Allen, AJ; Kelsey, D; Owens, J; Sangal, RB; Schuh, K; Sutton, V	1
Harpin, V; Jamdar, S; Poole, L; Prasad, S; Puvanendran, K; Zeitlin, H	1
Schlamp, D	1
Glaser, PE; Rush, CR; Stoops, WW; Vansickel, AR	1
Ahn, DH; Cho, SC; Du, Y; Gao, H; Kim, BN; Levine, LR; Marquez-Caraveo, ME; Shin, YJ; Song, DH; Wang, Y; Williams, DW; Zheng, Y	1
Chamberlain, SR; Robbins, TW; Sahakian, BJ	1
Allen, AJ; Ball, S; Bangs, ME; Dunn, D; Edison, T; Holdridge, KC; Jin, L; Wernicke, JF; Zhang, S	1
Katragadda, S; Schubiner, H	1
Allen, AJ; Bangs, ME; Cherlin, EA; Duesenberg, DA; Feldman, PD; Kelsey, DK; Quintana, H; Ramsey, JL	1
Young, JL	1
Comery, T; Day, M; Graf, R; Huang, Y; Hughes, Z; Logue, S; Navarra, R	1
McCarthy, J	1
Garcia-Bournissen, F; Humphreys, C; Ito, S; Koren, G	1
Birnbaum, HG; Ivanova, JI; Mallet, D; Wu, EQ; Yang, E; Zhang, HF	1
Goodman, DW	1
Asheim, H; Furu, K; Johansen, K; Nilsen, KB	1
Rostain, AL	1
Bevins, RA; Linkugel, JD; Reichel, CM	1
Gualtieri, CT; Johnson, LG	1
DeVane, CL; Donovan, JL; Gibson, BB; Jiang, Y; Markowitz, JS; Wang, JS; Zhu, HJ	1
Egger, HL; Emslie, GJ; Gleason, MM; Greenhill, LL; Kowatch, RA; Lieberman, AF; Luby, JL; Owens, J; Scahill, LD; Scheeringa, MS; Stafford, B; Wise, B; Zeanah, CH	1
Barton, R	1
Schlander, M	2
Allen, AJ; Casat, CD; Kratochvil, CJ; Michelson, D; Moore, RJ; Newcorn, JH; Ruff, DD	1
Vitiello, B	2
De Vries, TJ; Griffioen-Roose, S; Schiepers, OJ; Schoffelmeer, AN; Trezza, V; Van Leeuwen, N; Vanderschuren, LJ	1
Buermeyer, C; Faries, D; Khan, S; Saylor, K; Schuh, K; Sutton, V	1
Allen, AJ; Faries, DE; Jasinski, DR; Moore, RJ; Schuh, LM	1
Harpin, VA	1
Kratochvil, CJ; Vaughan, BS; Wetzel, MW	1
Adler, LA; Michelson, D; Moore, RJ; Spencer, TJ; Williams, DW	1
Heal, DJ; Kulkarni, RS; Rowley, HL; Smith, SL	1
Aarde, SM; Jentsch, JD; Seu, E	1
Findling, RL	1
Wilens, TE	1
Jentsch, JD; Lang, A; Rivera, RJ; Seu, E	1
Banaschewski, T; Döpfner, M; Rothenberger, A; Steinhausen, H-	1
Asherson, P; Banaschewski, T; Buitelaar, J; Coghill, D; Danckaerts, M; Döpfner, M; Faraone, SV; Rothenberger, A; Santosh, P; Sergeant, J; Sonuga-Barke, EJ; Steinhausen, HC; Taylor, E; Zuddas, A	1
Raj, YP	1
Kendall, T; Perez, A; Taylor, C; Taylor, E	1
Asherson, P; Coghill, D; de Soysa, R; Hollis, C; McCarthy, S; Murray, M; Potts, L; Sayal, K; Taylor, E; Williams, T; Wong, IC	1
Izaguerri-Gracia, AC; Valdizán, JR	1
Faber, A; Janknegt, R; Kalverdijk, LJ; Rodrigues Pereira, R	1
Arellano, J; Dilla, T; Hong, J	1
Einecke, U	1
Hadijikoumi, I; Keen, D	2
Dopheide, JA; Pliszka, SR	1
Jensen, PS	1
Dopheide, JA	1
Clement, HW; Gebhardt, S; Heiser, P; Krieg, JC; Schmidt, AJ; Schulz, E	1
Bloch, MH; Landeros-Weisenberger, A; Leckman, JF; Panza, KE	1
Fegert, JM; Kölch, M; Ludolph, AG; Plener, PL; Schulze, UM; Spröber, N	1
Cheetham, SC; Heal, DJ; Smith, SL	1
Niederhofer, H	2
Cranswick, N; McCarthy, S; Potts, L; Taylor, E; Wong, IC	1
Buitelaar, J; Medori, R	1
Brodziak, K; Doyle, RL; Georgiopoulous, A; Hammerness, P; Martelon, M; Schillinger, M; Utzinger, L; Wilens, TE	1
Biederman, J; Brodziak, K; Doyle, RL; Georgiopoulos, A; Hammerness, P; Martelon, M; Schillinger, M; Utzinger, L; Wilens, TE	1
Asherson, P; Bilbow, A; Clifford, S; Coghill, D; DeSoysa, R; Hollis, C; McCarthy, S; Murray, M; Planner, C; Potts, L; Sayal, K; Taylor, E; Wong, IC	1
Kratochvil, CJ; May, DE	1
Froehlich, TE; McGough, JJ; Stein, MA	1
Arra, C; Carboni, E; Carnevale, UA; Ibba, M; Melisi, D; Ruocco, LA; Sadile, AG; Schirru, C; Treno, C	1
Egberts, T; Heerdink, R; Souverein, P; Swaab, H; van den Ban, E; van Engeland, H	1
Bateman, N; Bond, C; Helms, PJ; Lee, AJ; McCaig, D; McLay, J; Stewart, D; Tobaiqy, M	1
Genro, JP; Hutz, MH; Kieling, C; Rohde, LA	1
Hu, TW; Lang, HC; Scheffler, RM	1
Ago, Y; Cong, Y; Kita, Y; Koda, K; Matsuda, T; Takuma, K	1
Clement, HW; Gebhardt, S; Heiser, P; Hemmeter, UM; Kircher, T; Krieg, JC; Schmidt, AJ; Schulz, E	1
Bigarella, MP; Hutz, MH; Polanczyk, G; Rohde, LA	1
Buitelaar, J; Casas, M; Konofal, E; Rösler, M	1
Bilker, WB; Cziraky, MJ; Daniel, GW; Guevara, J; Hennessy, S; Kimmel, SE; Schelleman, H; Strom, BL	1
Roman, MW	1
Caffino, L; Carboni, E; Cattaneo, A; Fumagalli, F; Gennarelli, M; Ibba, M; Racagni, G; Riva, MA	1
Besag, FM; Stiefel, G	1
Dickson, R; Granger, RE; Hazell, PL; Kohn, MR; Walton, RJ; Wyk, GW	1
Arnsten, AF; Gamo, NJ; Wang, M	1
Haynes, VS; Newcorn, JH; Sumner, CR; Teicher, MH	1
Hodgkins, P; Meijer, W; Sasané, R	1
Katz, JL; Koffarnus, MN	1
Hanania, T; Paterson, NE; Ricciardi, J; Wetzler, C	1
Findling, RL; Rowles, BM	1
Dalley, JW; Economidou, D; Everitt, BJ	1
Bizot, JC; David, S; Trovero, F	1
Agaoglu, B; Karakaya, I; Memik, NC; Sismanlar, SG; Yildiz, O	1
Curatolo, P; D'Agati, E; Moavero, R	1
Chae, S; Patel, A; Steinberg-Epstein, R; Wigal, SB	1
Bellgrove, MA; Cummins, TD; Dean, AJ; Garner, K; Hester, R; Kim, BN; Mattingley, JB; Nandam, LS; Nathan, PJ; Wagner, J	1
Egberts, TC; Heerdink, ER; Souverein, PC; Swaab, H; van den Ban, E; van Engeland, H	1
Kaplan, G; Newcorn, JH	1
Granger, RE; Hazell, PL; Kohn, MR; van Wyk, GW; Walton, RJ	1
De Simoni, S; Marquand, AF; Mehta, MA; Mourão-Miranda, J; O'Daly, OG; Williams, SC	1
Acosta, MT; Castellanos, FX	1
Fernández-Jaén, A; Martín Fernández-Mayoralas, D	1
Niederkirchner, K; Rettig, K; Schäuble, B; Slawik, L; Wermelskirchen, D	1
Arnsten, AF	1
Hodgkins, P; Meijer, WM; Sasané, R	1
Bonati, M; Didoni, A; Panei, P; Sequi, M	1
Lv, XZ; Shu, Z; Wu, SS; Zhan, SY; Zhang, YW	1
Bidwell, LC; Kollins, SH; McClernon, FJ	1
Franke, AG; Huss, M; Konrad, A; Lieb, K	1
Aspinall, AT; Caprioli, D; Dalley, JW; Economidou, D; Fernando, AB; Hipólito, L; Moreno, M; Newman, AH; Robbins, TW; Spoelder, M; Theobald, DE; Zou, MF	1
Robinson, ES	1
Barner, JC; Khoza, S; Oladapo, A	1
Cao, Q; Chan, RC; Li, H; Shuai, L; Wang, Y; Yang, L	1
de Silva, V; Hanwella, R; Senanayake, M	1
Hackett, A; Hanania, T; Paterson, NE; Wetzler, C	1
Chen, H; Chen, YH; Hong, YL; Lin, GX; Lin, XX; Liu, YY; Wei, LX	1
Cavanna, AE; Rickards, H; Worrall, R	1
Nielsen, NP; Wiig, EH	1
Baack, J; Erbe, K; Heinrich, H; Kratz, O; Malcherek, S; Moll, GH; Studer, P	1
Howland, RH	1
Alsop, DC; De Simoni, S; Maguire, RP; Marquand, AF; Mehta, MA; O'Daly, OG; Williams, SC; Zelaya, FO	1
Dockstader, C; Duerden, EG; Tannock, R	1
Karila, L	1
Bellgrove, MA; Hester, R; Mattingley, JB; Nandam, LS; Nathan, PJ; O'Connell, RG; Strudwick, M; Wagner, J	1
Bosch, R; Casas, M; Chalita, PJ; Palomar, G; Prats, L; Ramos-Quiroga, JA; Vidal, R	1
Chung, K; Duong, S; Wigal, SB	1
Bally-Cuif, L; Chaminade, M; Coolen, M; Lange, M; Lesch, KP; Merker, S; Norton, W; Proft, F; Schmitt, A; Vernier, P	1
Dalley, JW; Economidou, D; Everitt, BJ; Robbins, TW; Theobald, DE	1
Cooper, K; Daly, EJ; Gassmann-Mayer, C; Pandina, GJ; Weisler, RH	1
Asherson, P; Hodgkins, P; McCarthy, S; Murray, ML; Wilton, L; Wong, IC	2
Almarsdóttir, AB; Baldursson, G; Halldórsson, M; Hernández-Diaz, S; Huybrechts, KF; Jónsdóttir, S; Ólafsson, Ö; Rothman, KJ; Valdimarsdóttir, UA; Zoëga, H	1
Gluud, C; Simonsen, E; Storebø, OJ; Winkel, P	1
Ahn, JH; Cho, JH; Kim, IH; Kim, SK; Kwon, SH; Lee, CH; Lee, TH; Park, JH; Park, OK; Won, MH; Yan, BC	1
Banaschewski, T; Garbe, E; Kraut, AA; Langner, I; Lindemann, C; Mikolajczyk, RT; Petermann, F; Petermann, U; Schad-Hansjosten, T; Schreyer-Mehlhop, I	1
Faraone, SV; Fredriksen, M; Haavik, J; Halmøy, A	1
Heinrich, J; Heinrich-Weltzien, R; Heitmueller, D; Herbarth, O; Hickel, R; Kohlboeck, G; Koletzko, S; Kühnisch, J; Neumann, C; Tiesler, C	1
Bédard, AC; Clerkin, SM; Fan, J; Halperin, JM; Ivanov, I; Newcorn, JH; Schulz, KP; Tang, CY	1
Barrett, N; Brammer, MJ; Cubillo, A; Giampietro, V; Rubia, K; Simmons, A; Smith, AB	1
Bucci, DJ; Eggleston, RL; Robinson, AM	1
Pérez de los Cobos, J; Pérez, V; Siñol, N; Trujols, J	1
Bravaccio, C; Capuano, A; Granato, R; Grimaldi, G; Panei, P; Parretta, E; Pascotto, A; Rafaniello, C; Rinaldi, B; Rossi, F; Ruggiero, S; Sportiello, L	1
Banaschewski, T; Buitelaar, J; Coghill, D; Cortese, S; Danckaerts, M; Dittmann, RW; Graham, J; Holtmann, M; Sergeant, J; Taylor, E	1
Arcieri, R; Bonati, M; Chiarotti, F; Germinario, EA; Masi, G; Panei, P; Vella, S; Zuddas, A	2
Dwoskin, LP; Harvey, RC; Jordan, CJ; Kantak, KM; Moody, KR; Tassin, DH	1
Lensing, MB; Opjordsmoen, S; Sandvik, L; Zeiner, P	1
Connor, DF; Faraone, SV; Jensen, PS; Miesle, LM; Rostain, A	1
Asherson, P; Hodgkins, P; McCarthy, S; Murray, M; Wilton, L; Wong, IC	1
Bushe, CJ; Savill, NC	1
Alvarez-Gomez, MJ; Soutullo, C	1
Bloch, MH; Reichow, B; Volkmar, FR	1
Gau, SS; Huang, HC; Lin, YJ; Ni, HC; Yang, LK	1
Bahali, K; Ipek, H; Uneri, OS	1
Baird, AL; Barrot, M; Coogan, AN; Kaufling, J; Thome, J	1
Barrett, N; Brammer, M; Cubillo, A; Giampietro, V; Rubia, K; Simmons, A; Smith, AB	1
Eddy, JB; Good, MA; Humby, T; Reichelt, AC; Wilkinson, LS	1
Gau, SS; Huang, HC; Lin, YJ; Ni, HC; Shang, CY; Yang, LK	1
Barrett, N; Brammer, M; Cubillo, A; Giampietro, V; Rubia, K; Simmons, A; Smith, A	1
Deberdt, W; Kutzelnigg, A; Montoya, A; Ramos-Quiroga, JA; Sobanski, E	1
Arcieri, R; Panei, P	1
Hogmark, Å; Isaksson, J; Lindblad, F; Nilsson, KW	1
Miyajima, T; Tanaka, H	1
Calleja-Pérez, B; Fernández-Jaén, A; Fernández-Perrone, AL; López-Arribas, S; Martín Fernández-Mayoralas, D; Muñoz-Jareño, N	1
Aagaard, L; Hansen, EH	1
Berquin, P; Cardo, E; Danckaerts, M; De Bruyckere, K; Escobar, R; Fuentes, J; Montoya, A; Puvanendran, K; Quail, D	1
Barnes, JJ; Bellgrove, MA; Dean, AJ; Nandam, LS; O'Connell, RG	1
Dalsgaard, S; Nielsen, HS; Simonsen, M	1
Castellanos, FX; Meyer, E	1
Clark, BD; Navarra, RL; Waterhouse, BD; Zitnik, GA	1
Reddy, DS	1
Couture, J; Sharma, A	1
Anagnostaras, SG; Carmack, SA; Howell, KK; Rasaei, K; Reas, ET	1
Brennan, CH; Brock, AJ; Parker, MO; Sudwarts, A	1
Bellgrove, MA; Hester, R; Nandam, LS	1
Akbulat, A; Gürsöz, H; Karadağ, H; Kerman, S; Öner, Ö; Türkçapar, H; Vural, EH; Vural, M; Yilmaz, EŞ	1
Ishizaki, A; Sugama, M	1
Hodgkins, P; Roskell, NS; Setyawan, J; Zimovetz, EA	1
Evans, SW; Kuriyan, AB; Sibley, MH; Smith, BH; Waxmonsky, JG	1
Bittsansky, M; Dobrota, D; Husarova, V; Ondrejka, I	1
Geirs, DP; Halldórsson, M; Pottegård, A; Zoëga, H	1
Altin, M; Desaiah, D; El-Shafei, A; Faries, D; Feng, Q; Gado, M; Serebryakova, E; Treuer, T; Wu, S	1
Bonati, M; Clavenna, A	1
Baskin, BB; Dwoskin, LP; Harvey, RC; Jordan, CJ; Kantak, KM	1
Davies, W; Eddy, JB; Humby, T; Ojarikre, OA; Trent, S; Wilkinson, LS	1
Barnes, SA; Grayson, B; Harte, MK; Marsh, S; Marshall, KM; Neill, JC; Tomlinson, A	1
Bardo, MT; Charnigo, R; Gipson, CD; Meyer, AC; Perry, JL; Yates, JR	1
Dommett, EJ	1
Chen, Q; D'Onofrio, BM; Larsson, H; Lichtenstein, P; Runeson, B; Sjölander, A	1
Bédard, AC; Halperin, JM; Krone, B; Newcorn, JH; Rajwan, E; Stein, MA	1
Ahn, YJ; Cheong, JH; Gao, Q; Kwon, G; Lee, HE; Lee, Y; Park, SJ; Ryu, JH; Shin, CY; Woo, H	1
Bell, EA; Eiland, LS; Erramouspe, J	1
Heyd, A; Nohr, FI; Norum, J; Olsen, AI; Totth, A	1
Arun, P; Chavan, BS; Garg, J	1
Aagaard, L; Hansen, EH; Warrer, P	1
Awudu, GA; Besag, FM	1
Bjerregaard, BK; Kortegaard, LS; Pottegård, A; Zoëga, H	1
Alegría, AA; Brinson, H; Rubia, K	1
Gandía-Benetó, R; Mulas, F; Ortiz-Sánchez, P; Roca, P; Ros-Cervera, G	1
Durand, M; Gow, R; Guertin, J; Holbrook, A; LeLorier, J; Levine, M	1
McLennan, JD; Vallerand, IA; Wagner, DJ	1
Banaschewski, T; Dittmann, RW; Wehmeier, PM	1
Dahl, AA; Fredriksen, M; Haavik, J; Klungsøyr, O; Martinsen, EW; Peleikis, DE	1
Achterberg, EJ; Damsteegt, R; Trezza, V; van Kerkhof, LW; Vanderschuren, LJ	1
Di Miceli, M; Gronier, B	1
Garbe, E; Horn, J; Langner, I; Lindemann, C; Mikolajczyk, R; Schmedt, N	1
Hägglöf, B; Jacobsson, L	1
Dalhoff, KP; Jensen, LS; Pagsberg, AK	1
Locatelli, I; Štuhec, M; Švab, V	1
Locatelli, I; Munda, B; Stuhec, M; Svab, V	1
French, WP	1
García-Gil, M; Izquierdo-María, R; Librero, J; Peiró, S	1
Adeyi, B; Anderson, CS; Caballero, B; Cardo, E; Coghill, DR; Häge, A; Nagy, P; Sikirica, V	1
Abikoff, H; Greenhill, LL; Kollins, SH; Lazzaretto, D; McCracken, JT; McGough, JJ; Paykina, N; Riddle, MA; Vitiello, B; Wigal, S; Wigal, T; Yershova, K	1
Brown, EN; Kenny, JD; Solt, K; Taylor, NE	1
Aalderink, M; Achterberg, EJ; Driel, NV; Houwing, DJ; Servadio, M; Trezza, V; van Kerkhof, LW; van Swieten, MM; Vanderschuren, LJ	1
Ince Tasdelen, B; Karakaya, E; Oztop, DB	1
Gau, SS; Huang, LW; Lin, HY; Pan, YL; Shang, CY	1
Atar, B; Aydin, C; Kose, S; Ozbaran, B; Yuzuguldu, O	1
Dalsgaard, S; Leckman, JF; Mortensen, PB; Nielsen, HS; Simonsen, M	1
Arcieri, R; Capuano, A; Chiarotti, F; Cortese, S; Curatolo, P; Germinario, EA; Margari, L; Panei, P	1
Dörfelt, A; Haen, E; Stegmann, B	1
Fredriksen, M; Peleikis, DE	1
Chia, S; Chou, TL; Gau, SS; Shang, CY	1
Lee, MJ; Lee, SY; Lee, TL; Shyu, YC; Wang, LJ; Yang, CJ; Yang, KC; Yuan, SS	1
Barkla, XM; McArdle, PA; Newbury-Birch, D	1
Lee, SY; Lee, TL; Shyu, YC; Wang, LJ; Yang, CJ; Yang, KC; Yuan, SS	3
Hrtanek, I; Kulhan, T; Marcincakova-Husarova, V; Nosalova, G; Ondrejka, I; Snircova, E	1
Guerrero-Álvarez, Á; Juárez, J	1
Chen, Y; Montgomery, W; Treuer, T; Wang, F; Wang, K; Wang, WQ; Wu, SH	1
Ago, Y; Hara, Y; Hasebe, S; Hashimoto, H; Katashiba, K; Matsuda, T; Onaka, Y; Takano, E; Takuma, K; Taruta, A	1
Agster, KL; Bradshaw, SE; McGaughy, JA; Waterhouse, BD	1
Cao, Q; Stein, MA; Su, Y; Wang, Y; Yang, L	1
Merrill, RM; Palmer, CA; Thygerson, SM	1
Aagaard, L; Dalsgaard, S; Hansen, EH; Rasmussen, HB; Thomsen, PH; Wallach Kildemoes, H; Warrer, P	1
Gau, SS; Huang, HC; Hwang Gu, SL; Lin, HY; Lin, YJ; Ni, HC; Yang, LK	1
Bonati, M; Cartabia, M; Didoni, A; Fortinguerra, F; Mondini, M; Reale, L; Zanetti, M	1
Berggren, L; Bushe, C; Day, K; Haynes, V; Karlsdotter, K; Pitcher, A; Reed, V; Televantou, F	1
Şanlı, I; Semerci, B; Taskıran, S; Tufan, E	1
Chan, E; Fogler, JM; Hammerness, PG	1
Chou, MC; Chou, WJ; Huang, TS; Lee, MJ; Lee, SY; Lee, TL; Shyu, YC; Wang, LJ; Yang, CJ; Yang, KC; Yuan, SS	1
Demirci, E; Erdogan, A	1
Bahn, GH; Bhang, SY; Choi, HY; Chung, US; Hong, M; Hwang, JW; Joung, YS; Kim, B; Kwak, YS; Lee, S; Lee, YJ; Oh, IH; Sohn, SH; Yang, J	1
Bussing, R; Kubilis, P; Liu, X; Winterstein, AG	1
Beard, SM; Bischof, M; Hodgkins, P; Mauskopf, JA; Setyawan, J; Zimovetz, EA	1
Castellanos, FX; Gau, SS; Lin, HY; Shang, CY; Tseng, WY; Yan, CG	1
Bahmanyar, S; Furu, K; Karlstad, Ø; Kieler, H; Martikainen, JE; Pottegård, A; Zoëga, H	1
Gao, J; He, S; Li, Y; Wang, Q; Zhang, Y	1
Kapellen, TM; Kiess, W; Kostev, K; Reimann, R	1
Chen, YJ; Curtice, TG; Greven, P; Makin, C; Sikirica, V	1
Jain, R; Katic, A	1
Csemy, L; Dezortova, M; Hajek, M; Kohoutova, M; Kollarova, P; Paclt, I; Pribilova, N	1
Han, DH; Lee, YS; Park, JH; Sohn, JH	1
Shin, JY; Song, I	1
Anderson, RH; Mattingly, GW	1
Fang, Q; Liu, Q; Qin, L; Zhang, H	1
Connemann, BJ; Gahr, M; Schönfeldt-Lecuona, C; Zeiss, R	1
Bakker, MJ; Banaschewski, T; Buitelaar, JK; Carucci, S; Coghill, D; Danckaerts, M; Dittmann, RW; Hennissen, L; Hollis, C; Kovshoff, H; McCarthy, S; Nagy, P; Rosenthal, E; Sonuga-Barke, E; Wong, IC; Zuddas, A	1
Borges Dos Reis, C; Chierrito de Oliveira, D; Cristina Conegero Sanches, A; Fernandez-Llimos, F; Guerrero de Sousa, P; Maria Steimbach, L; Pontarolo, R; Tonin, FS; Virtuoso, S	1
Locatelli, I; Stuhec, M	2
Blanco, L; Capellà, D; Castells, X; Cunill, R; Riera, M; Tobias, A	1
Lee, EK; Lee, MS; Shin, JY; Song, I	1
Asherson, P; Cooper, RE; Moran, P; Moukhtarian, TR; Vassos, E	1
White, T	1
Bédard, AV; Fan, J; Halperin, JM; Hildebrandt, TB; Ivanov, I; Newcorn, JH; Schulz, KP; Stein, MA	1
Baskin, BM; Dwoskin, LP; Kantak, KM; Nic Dhonnchadha, BÁ	1
Cheong, JH; de la Peña, JB; Dela Peña, I; Dela Peña, IJ; Han, DH; Kim, BN; Kim, HJ; Ryu, JH; Shin, CY	1
Cortese, S; Harris, J; Lenzi, F; Masi, G	1
Naguy, A	1
Bateman, BT; Cohen, JM; Desai, RJ; Gray, KJ; Hernández-Díaz, S; Huybrechts, KF; Mogun, H; Park, Y; Patorno, E	1
Alkam, T; Kim, HC; Mamiya, T; Nabeshima, T; Nitta, A; Tanaka, J; Toriumi, K	1
Charman, T; Findon, JL; Howes, OD; King, BH; Loth, E; McAlonan, GM; McCracken, JT; Murphy, DG; Parr, JR; Povey, C; Rogdaki, M; Santosh, P; Simonoff, E; Wallace, S; Wichers, RH	1
Brown, JW; Ding, Z; Mohler, EG; Rueter, LE	1
Anagnostou, E	1
Hasegawa, M; Horiguchi, N; Jino, K; Kano, T; Kobayashi, M; Nishitomi, K; Shinohara, S; Yano, K	1
Bai, YM; Chang, WH; Chen, MH; Chen, TJ; Hsu, JW; Huang, KL; Li, CT; Lin, WC; Su, TP; Tsai, SJ; Wei, HT	1
Farsky, I; Hrtanek, I; Marcincakova Husarova, V; Nosalova, G; Ondrejka, I; Snircova, E	1
Cichocki, A; Hasegawa, M; Hiroyama, S; Horiuchi, M; Jurica, P; Li, J; Nishitomi, K; Ogawa, K; Struzik, ZR; Takahara, Y; Yokota, T	1
Jang, B; Jeong, B; Joung, YS; Kim, J; Kim, K; Kim, S; Kim, YH; Kwon, JY; Lee, J; Oh, Y; Shin, HY; Song, J; Yoo, JH	1
Casavant, MJ; Chounthirath, T; Hodges, NL; King, SA; Smith, GA; Spiller, HA	1
Fujita, J; Iida, J; Negoro, H; Okada, T; Okumura, Y; Saito, T; Tsujii, N; Usami, M	1
Osland, ST; Pringsheim, T; Steeves, TD	1
Ho, CS; Ho, RC; Liang, EF; Lim, SZ; McIntyre, RS; Tam, WW; Zhang, MW	1
Bernadzikowski, T; Boris, JR	1
Bahmanyar, S; Berard, A; Bilder, S; Boukhris, T; Bushnell, G; Chan, EW; Coghill, D; Crystal, S; Furu, K; Ip, P; KaoYang, YH; Karlstad, Ø; Kieler, H; Kubota, K; Lai, EC; Macias Saint-Gerons, D; Man, KKC; Martikainen, JE; Maura, G; Montero, D; Moore, N; Nakamura, H; Neumann, A; Pate, V; Pottegård, A; Pratt, NL; Raman, SR; Roughead, EE; Sturkenbroom, MCJM; Stürmer, T; Su, CC; Wong, ICK; Zoega, H	1
Brambilla, P; Crippa, A; Grazioli, S; Maggioni, E; Mauri, M; Molteni, M; Nobile, M	1
Chierrito, D; Fernandez-Llimos, F; Sanches, ACC; Tonin, FS; Villas-Boas, CB	1
Gau, SS; Shang, CY; Shih, HH	1
Carvalho, AF; Correll, CU; de Bartolomeis, A; Fornaro, M; Köhler, CA; Solmi, M; Stubbs, B; Toyoshima, K; Veronese, N	1
Andreasen, JT; Caballero-Puntiverio, M; Dietz, AG; Grupe, M; Larsen, CW; Lerdrup, LS	1
Su, CC; Tsai, CY; Tsai, IJ; Tsai, TH	1
Cappelletti, S; Chetoni, C; Kotzalidis, GD; Pasquini, M; Piacentino, D; Sani, G	1
Andreasen, JT; Fitzpatrick, CM	1
Cardo-Jalón, E; López-López, A; López-Pisón, J; Poch-Olivé, ML	1
France, CP; Maguire, DR	1
Barnes, JJM; Bellgrove, MA; Brosnan, MB; Dean, A; Loughnane, GM; Nandam, SL; O'Connell, RG	1
Kikuchi, S; Mano, N; Morikawa, Y; Obara, T; Ooba, N; Satoh, M; Yamaguchi, H; Yoshida, M	1
Chierrito, D; de Mello, JCP; Fernandez-Llimos, F; Sanches, ACC; Tonin, FS; Villas-Boas, CB	1
Munasur-Naidoo, AP; Truter, I	1
Adorjan, K; Erbas, B; Hantschk, I; Karch, S; Koller, G; Martin, G; Plörer, D; Pogarell, O; Winter, C	1
Barrett, N; Brammer, M; Cubillo, AI; Giampietro, V; Kowalczyk, OS; Rubia, K; Simmons, A; Smith, A	1
Andreasen, JT; Arvastson, L; Aznar, S; Caballero-Puntiverio, M; Lerdrup, LS	1
Contreras, D; Hardy, P; Morales, B; Piña, R; Rojas, P; Rozas, C; Ugarte, G; Zeise, ML	1
Coghill, D; Efron, D; Hearps, S; Hiscock, H; Mulraney, M; Sciberras, E	1
Shen, G; Shi, WX	1
Castells, X; Cunill, R; Olivé, C; Ramon, M; Serrano, D	1
Banaschewski, T; Häge, A; Hohmann, S; Millenet, S	1
Sarıgedik, E; Tufan, AE; Yektaş, Ç	1
Hagiwara, M; Kimura, R; Maegawa, S; Nakata, M; Suzuki, S	1
Cubuk, M; Gunes, S; Guvenmez, O	1
Miller, J; Perera, B; Shankar, R	1
Grimmsmann, T; Himmel, W	1
Ameis, SH; Anagnostou, E; Anderson, KK; Beswick, A; Gorman, DA; Lai, MC; Rodrigues, R; Szatmari, P	1
Je, NK; Kim, E; Kim, Y; Park, S	1
Cortese, S	1
Fuermaier, ABM; Groen, Y; Kok, FM; Tucha, O	1
Bai, Z; Charach, A; Chojecki, D; Eagles, C; Elliott, J; Hossain, A; Hsieh, SC; Husereau, D; Johnston, A; Kelly, SE; Mamdani, M; Skidmore, B; Tsakonas, E; Wells, GA	1
Castellanos, FX; de Castro-Manglano, P; Franco, AR; Milham, MP; Pereira-Sanchez, V; Soutullo, C; Vieira, D	1
Biederman, J; Firmin, ES; Hoskova, B; Joshi, G; Wilens, T	1
Bloch, MH; Farhat, LC	1
Hayakawa, S; Hino, H; Ito, M; Kikuchi, D; Miura, R; Obara, T; Shiozawa, M; Takahashi, A; Tokunaga, M; Watanabe, Y	1
Iannucci, GJ; Lynn, M; McCracken, CM; Oster, ME; Pierick, AR	1
Adil, KJ; Cheong, JH; Han, SH; Jeon, SJ; Kim, HJ; Kim, HY; Kim, R; Kwon, KJ; Mabunga, DFN; Park, D; Ryu, O; Shin, CY; Valencia, S	1
Hakosima, Y; Harada, I; Inazaki, K; Itagaki, K; Kurokouchi, T; Mizumoto, Y; Namekata, S; Okada, T; Saito, K; Sasaki, S; Sasaki, Y; Shinohara, R; Sugimoto, K; Sunakawa, H; Takahashi, M; Tanase, S; Toguchi, Y; Tsujii, N; Usami, M; Yoshida, Y; Yoshimura, Y	1
Arranz, B; Arrojo, M; Becoña, E; Bernardo, M; Castells, X; Cunill, R; Flórez, G; Fonseca, F; Garriga, M; Goikolea, JM; González-Pinto, A; López, A; Sáiz, PA; San, L; Tirado-Muñoz, J; Torrens, M; Zorrilla, I	1
Banaschewski, T; Häge, A; Hohmann, S; Mechler, K	1
Fife, D; Hardin, J; Rofael, H; Ryan, PB; Solomon, ID; Stang, P; Voss, EA	1
Chen, J; Chen, L; Cheng, Q; Deng, L; Li, T; Yang, T; Zhang, Y; Zhao, Q; Zhou, P; Zhu, L	1
Akmatov, MK; Bätzing, J; Holstiege, J	1
Coghill, D; Cortese, S; Newcorn, JH	1
Stevenson, J	1
Dubrall, D; Leitzen, S; Neubert, A; Sachs, B; Schmid, M; Schulz, M; Stingl, J; Toni, I	1
Banaschewski, T; Bölte, S; Buitelaar, JK; Coghill, D; Cortese, S; Häge, A; Hohmann, S; Jonsson, U; Nobel Norrman, H; Pan, PY; Şahpazoğlu Çakmak, SS	1
Alunno, A; Hughes, M; Matucci-Cerinic, M; Sandler, RD; Umair, HM	1
Arnold, LE; Arns, M; Breteler, R; DeBeus, R; Denys, D; du Jour, P; Gordon, E; Griffiths, KR; Jansen, J; Korgaonkar, MS; Loo, SK; Michelini, G; Palmer, D; van Dijk, H; van Ruth, R; van Wingen, G; Voetterl, H	1
Cortese, S; Groom, MJ	1
Cao, Q; Fu, Z; Hu, N; Pei, X; Wang, Y; Xie, R; Xu, C; Yang, L; Yuan, J; Zhang, K; Zhao, Y	1
Higgins, GA; Silenieks, LB	1
Surman, CBH; Walsh, DM	1
Andersen, JH; Cesta, CE; Furu, K; Hartz, I; Rasmussen, L; Reutfors, J; Sørensen, AMS; Wesselhöeft, R	1
Paric, A; Patterson, B; Pipe, A; Ravindran, AV; Ravindran, N; Van Ameringen, M	1
Brown, JT	1
Andrillon, T; Bellgrove, MA; Dockree, PM; O'Connell, RG; Pinggal, E	1
Böker, KO; Di Fazio, P; Jäckle, K; Lehmann, W; Schilling, AF; Wagener, N; Weiser, L	1
Chatterjee, M; Maitra, S; Mukhopadhyay, K; Ray, A; Saha, S; Sinha, S	1
Beltran-Navarro, B; Galvez-Contreras, AY; Gonzalez-Castaneda, RE; Gonzalez-Perez, O; Vargas-de la Cruz, I	1
Andriambeloson, E; Christensen, C; Karlsson, KÆ; Lavalou, P; Norton, WHJ; Parker, MO; Shkumatava, A; Sveinsdóttir, HS; Wagner, S; Þorsteinsson, H	1
Gether, U; Hervig, ME; Petersen, A; Robbins, TW; Toschi, C; Vangkilde, S	1
Cesta, CE; Cohen, JM; Furu, K; Karlstad, Ø; Reutfors, J; Srinivas, C	1
Buunk, AM; de Boer-Veger, NJ; Deneer, VHM; Guchelaar, HJ; Houwink, EJF; Jama, WOM; Nijenhuis, M; Risselada, A; Rongen, GA; Soree, B; Swen, JJ; Touw, D; van der Weide, J; van Schaik, RHN; van Westrhenen, R	1
Ba-M'hamed, S; Bennis, M; Landry, M; Sifeddine, W	1
Gau, SS; Hsu, CN; Liao, HC; Lin, FJ; Wang, CC	1
Gillies, D; Leach, MJ; Perez Algorta, G	1
Becker, SP; Froehlich, TE; Wiggs, KK	1
Bueno, CDF; Correa, RDESA; Dias, ACM; Rocha, NS	1
Criaud, M; Cubillo, AI; Giampietro, V; Kowalczyk, OS; Mehta, MA; O'Daly, OG; Rubia, K	1

Reviews

128 review(s) available for atomoxetine hydrochloride and methylphenidate

Article	Year
Adults with attention-deficit/hyperactivity disorder: a controversial diagnosis. The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 7 Topics: Adolescent; Adult; Age Factors; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clinical Trials as Topic; Comorbidity; Desipramine; Humans; Mental Disorders; Methylphenidate; Propylamines; Reproducibility of Results; Retrospective Studies; Severity of Illness Index; Syndrome	1998
[Medical treatments of hyperactive child]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2004, Volume: 11, Issue:1 Topics: Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; Child; Combined Modality Therapy; Humans; Methylphenidate; Propylamines	2004
Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder. The international journal of neuropsychopharmacology, 2004, Volume: 7, Issue:1 Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Clonidine; Delayed-Action Preparations; Evidence-Based Medicine; Guanfacine; Humans; Methylphenidate; Propylamines	2004
Pharmacological management of attention-deficit hyperactivity disorder. Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:6 Topics: Adrenergic alpha-Agonists; Amphetamines; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Clonidine; Guanfacine; Humans; Methylphenidate; Propylamines	2004
New drugs for the treatment of attention-deficit/hyperactivity disorder. Expert opinion on emerging drugs, 2004, Volume: 9, Issue:2 Topics: Amphetamines; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Humans; Methylphenidate; Propylamines	2004
Pharmacotherapy of adult ADHD. Journal of clinical psychology, 2005, Volume: 61, Issue:5 Topics: Adolescent; Adult; Age Factors; Amphetamine; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; Child; Combined Modality Therapy; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Methylphenidate; Propylamines; Treatment Outcome	2005
Treatment of attention-deficit/hyperactivity disorder: overview of the evidence. Pediatrics, 2005, Volume: 115, Issue:6 Topics: Adolescent; Antidepressive Agents, Tricyclic; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Caregivers; Central Nervous System Stimulants; Child; Combined Modality Therapy; Dextroamphetamine; Evidence-Based Medicine; Family; Female; Humans; Male; Methylphenidate; Norepinephrine Plasma Membrane Transport Proteins; Pemoline; Practice Guidelines as Topic; Propylamines; Randomized Controlled Trials as Topic; Stress, Psychological; Symporters	2005
Righting a troubled course. Diagnosing and treating ADHD in adults. Advance for nurse practitioners, 2005, Volume: 13, Issue:8 Topics: Adult; Age Factors; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Comorbidity; Humans; Methylphenidate; Nurse Practitioners; Nursing Assessment; Practice Guidelines as Topic; Primary Health Care; Propylamines	2005
[The effectiveness of atomoxetine in children, adolescents, and adults with ADHD. A systematic overview]. Der Nervenarzt, 2006, Volume: 77, Issue:3 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clinical Trials as Topic; Humans; Methylphenidate; Norepinephrine Plasma Membrane Transport Proteins; Propylamines; United States; United States Food and Drug Administration	2006
Attention deficit hyperactivity disorder in children. Clinical evidence, 2005, Issue:13 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Combined Modality Therapy; Dextroamphetamine; Humans; Methylphenidate; Propylamines; Psychotherapy	2005
Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents: update on new stimulant preparations, atomoxetine, and novel treatments. Child and adolescent psychiatric clinics of North America, 2006, Volume: 15, Issue:1 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Humans; Methylphenidate; Norepinephrine; Propylamines	2006
Attention deficit hyperactivity disorder--a review for family physicians. Indian journal of medical sciences, 2005, Volume: 59, Issue:12 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; Child; Combined Modality Therapy; Comorbidity; Early Diagnosis; Family Practice; Humans; Methylphenidate; Propylamines	2005
Attention deficit hyperactivity disorder, tics and Tourette's syndrome: the relationship and treatment implications. A commentary. European child & adolescent psychiatry, 2006, Volume: 15, Issue:1 Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Humans; Methylphenidate; Propylamines; Tics; Tourette Syndrome	2006
Attention deficit/hyperactivity disorder: complexities and controversies. Current opinion in pediatrics, 2006, Volume: 18, Issue:2 Topics: Administration, Cutaneous; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior; Central Nervous System Stimulants; Child; Dose-Response Relationship, Drug; Humans; Methylphenidate; Propylamines; Risk Factors	2006
Pharmacological treatment of attention-deficit/hyperactivity disorder in adults. Expert opinion on investigational drugs, 2006, Volume: 15, Issue:6 Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Tricyclic; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Desipramine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Methylphenidate; Propylamines; Randomized Controlled Trials as Topic	2006
A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents. Health technology assessment (Winchester, England), 2006, Volume: 10, Issue:23 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Cost-Benefit Analysis; Dextroamphetamine; Humans; Methylphenidate; Models, Economic; Propylamines; Treatment Outcome	2006
Atomoxetine. Indian pediatrics, 2006, Volume: 43, Issue:7 Topics: Administration, Oral; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Humans; Methylphenidate; Propylamines	2006
Attention deficit hyperactivity disorder in children. Clinical evidence, 2006, Issue:15 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Combined Modality Therapy; Dextroamphetamine; Humans; Methylphenidate; Propylamines; Psychotherapy	2006
Meta-analysis of aggression or hostility events in randomized, controlled clinical trials of atomoxetine for ADHD. Biological psychiatry, 2007, Mar-01, Volume: 61, Issue:5 Topics: Adolescent; Adrenergic Uptake Inhibitors; Aged; Aggression; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Databases as Topic; Double-Blind Method; Female; Hostility; Humans; Male; Methylphenidate; Middle Aged; Odds Ratio; Proportional Hazards Models; Propylamines	2007
[My child is so restless]. MMW Fortschritte der Medizin, 2007, Mar-08, Volume: 149, Issue:10 Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Biofeedback, Psychology; Central Nervous System Stimulants; Child; Counseling; Diagnosis, Differential; Humans; Methylphenidate; Propylamines; Time Factors	2007
Update on drugs for hyperactivity in childhood. Drug and therapeutics bulletin, 2007, Volume: 45, Issue:5 Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Dextroamphetamine; Drug Costs; Humans; Methylphenidate; Propylamines; Treatment Outcome	2007
ADHD in children, adolescents, and adults. Primary care, 2007, Volume: 34, Issue:2 Topics: Adolescent; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavioral Medicine; Central Nervous System Stimulants; Child; Comorbidity; Family Practice; Humans; Methylphenidate; Pediatrics; Primary Health Care; Propylamines; Risk Factors	2007
Children with autism spectrum disorders and intellectual disability. Current opinion in psychiatry, 2007, Volume: 20, Issue:5 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Central Nervous System Stimulants; Child; Humans; Intellectual Disability; Methylphenidate; Prevalence; Propylamines	2007
Exposure to attention deficit hyperactivity disorder medications during pregnancy. Canadian family physician Medecin de famille canadien, 2007, Volume: 53, Issue:7 Topics: Abnormalities, Drug-Induced; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Congenital Abnormalities; Decision Making; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant, Newborn; Methylphenidate; Pregnancy; Pregnancy Complications; Propylamines; Risk Assessment	2007
The consequences of attention-deficit/hyperactivity disorder in adults. Journal of psychiatric practice, 2007, Volume: 13, Issue:5 Topics: Achievement; Adult; Age Factors; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Disease Progression; Female; Health Care Costs; Humans; Impulsive Behavior; Male; Mental Disorders; Methylphenidate; Propylamines; Quality of Life; Sex Distribution; Social Adjustment; Substance-Related Disorders	2007
Psychopharmacological treatment for very young children: contexts and guidelines. Journal of the American Academy of Child and Adolescent Psychiatry, 2007, Volume: 46, Issue:12 Topics: Algorithms; Amphetamines; Antidepressive Agents; Antipsychotic Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child Psychiatry; Child, Preschool; Drug Prescriptions; Humans; Mental Disorders; Methylphenidate; Propylamines; Psychopharmacology; Risperidone	2007
Use of medication in children with psychiatric disorders. Community practitioner : the journal of the Community Practitioners' & Health Visitors' Association, 2007, Volume: 80, Issue:11 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Child Psychiatry; Drug Prescriptions; Drug Utilization; Fluoxetine; Fluvoxamine; Health Policy; Humans; Melatonin; Mental Disorders; Methylphenidate; Needs Assessment; Patient Selection; Practice Guidelines as Topic; Practice Patterns, Physicians'; Propylamines; Psychotropic Drugs; Risperidone; Sertraline; United Kingdom	2007
Has NICE got it right? An international perspective considering the case of Technology Appraisal No. 98 by the National Institute for Health and Clinical Excellence (NICE). Current medical research and opinion, 2008, Volume: 24, Issue:4 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cost-Benefit Analysis; Dextroamphetamine; Germany; Humans; Internationality; Methylphenidate; Propylamines; Quality-Adjusted Life Years; Technology Assessment, Biomedical; United States	2008
Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular function. Child and adolescent psychiatric clinics of North America, 2008, Volume: 17, Issue:2 Topics: Adolescent; Adrenergic Uptake Inhibitors; Appetite; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Body Height; Central Nervous System Stimulants; Child; Child, Preschool; Controlled Clinical Trials as Topic; Death, Sudden, Cardiac; Electrocardiography; Heart Rate; Humans; Long-Term Care; Methylphenidate; Propylamines; Risk Factors	2008
Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006. Archives of disease in childhood. Education and practice edition, 2008, Volume: 93, Issue:2 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Dextroamphetamine; Humans; Methylphenidate; Practice Guidelines as Topic; Propylamines	2008
Beyond the 'typical' patient: treating attention-deficit/hyperactivity disorder in preschoolers and adults. International review of psychiatry (Abingdon, England), 2008, Volume: 20, Issue:2 Topics: Adult; Age Factors; Age of Onset; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child, Preschool; Cognitive Behavioral Therapy; Comorbidity; Humans; Mental Disorders; Methylphenidate; Propylamines; Psychology	2008
New perspectives from microdialysis studies in freely-moving, spontaneously hypertensive rats on the pharmacology of drugs for the treatment of ADHD. Pharmacology, biochemistry, and behavior, 2008, Volume: 90, Issue:2 Topics: Amphetamine; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Disease Models, Animal; Dopamine; Humans; Methylphenidate; Microdialysis; Norepinephrine; Propylamines; Rats; Rats, Inbred SHR; Rats, Inbred WKY	2008
[What's new about hyperactivity disorder in children?]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2008, Volume: 15, Issue:7 Topics: Adrenergic Uptake Inhibitors; Age Factors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Cognitive Behavioral Therapy; Combined Modality Therapy; Delayed-Action Preparations; Drug Combinations; Ferrous Compounds; France; Humans; Methylphenidate; Mucins; Propylamines; Psychotherapy; Speech Therapy; Time Factors	2008
Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review. Clinical therapeutics, 2008, Volume: 30, Issue:5 Topics: Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dexmethylphenidate Hydrochloride; Humans; Methylphenidate; Norepinephrine Plasma Membrane Transport Proteins; Prodrugs; Propylamines	2008
[Long-acting medications for the treatment of hyperkinetic disorders - a systematic review and European treatment guidelines. Part 2: a quantitative evaluation of long-acting medications]. Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie, 2008, Volume: 36, Issue:2 Topics: Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Europe; Evidence-Based Medicine; Humans; Methylphenidate; Practice Guidelines as Topic; Propylamines; Quality of Life; Treatment Outcome	2008
InforMatrix for attention deficit hyperactivity disorder. Expert opinion on pharmacotherapy, 2009, Volume: 10, Issue:5 Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Chemistry, Pharmaceutical; Clinical Trials as Topic; Humans; Methylphenidate; Netherlands; Propylamines	2009
ADHD in children and adolescents. BMJ clinical evidence, 2008, Oct-02, Volume: 2008 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Child; Dextroamphetamine; Diagnostic and Statistical Manual of Mental Disorders; Humans; Methylphenidate	2008
Attention-deficit-hyperactivity disorder: an update. Pharmacotherapy, 2009, Volume: 29, Issue:6 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Amphetamine; Antidepressive Agents, Second-Generation; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Case-Control Studies; Central Nervous System Stimulants; Child; Conduct Disorder; Follow-Up Studies; Humans; Juvenile Delinquency; Longitudinal Studies; Methylphenidate; Patient Compliance; Prescriptions; Prevalence; Propylamines; Substance-Related Disorders; Time Factors; Treatment Outcome; United States	2009
Clinical considerations for the diagnosis and treatment of ADHD in the managed care setting. The American journal of managed care, 2009, Volume: 15, Issue:5 Suppl Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Diagnostic and Statistical Manual of Mental Disorders; Dopamine Uptake Inhibitors; Humans; Managed Care Programs; Methylphenidate; Propylamines	2009
The role of pharmacotherapy and managed care pharmacy interventions in the treatment of ADHD. The American journal of managed care, 2009, Volume: 15, Issue:5 Suppl Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Humans; Managed Care Programs; Medication Adherence; Methylphenidate; Propylamines	2009
Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 2009, Volume: 48, Issue:9 Topics: Adrenergic alpha-Agonists; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Comorbidity; Contraindications; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Methylphenidate; Propylamines; Psychotropic Drugs; Randomized Controlled Trials as Topic; Tic Disorders; Tourette Syndrome	2009
[Attention Deficit Hyperactivity Disorder (ADHD) and road traffic - special considerations for the treatment of adolescents with ADHD]. Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie, 2009, Volume: 37, Issue:5 Topics: Accidents, Traffic; Adolescent; Adrenergic Uptake Inhibitors; Adult; Amphetamines; Atomoxetine Hydrochloride; Attention; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Female; Germany; Humans; Male; Methylphenidate; Propylamines; Substance Abuse Detection; Young Adult	2009
The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety. Neuropharmacology, 2009, Volume: 57, Issue:7-8 Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain; Catecholamines; Central Nervous System Stimulants; Dopamine Agents; Humans; Methylphenidate; Propylamines; Stereoisomerism; Substance-Related Disorders	2009
Treating attention-deficit/hyperactivity disorder beyond symptom control alone in children and adolescents: a review of the potential benefits of long-acting stimulants. European child & adolescent psychiatry, 2010, Volume: 19, Issue:4 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Humans; Methylphenidate; Personality Development; Propylamines; Quality of Life; Social Perception; Treatment Outcome	2010
Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics. CNS drugs, 2010, Volume: 24, Issue:2 Topics: Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Catechol O-Methyltransferase; Central Nervous System Stimulants; Dopamine Plasma Membrane Transport Proteins; Humans; Inactivation, Metabolic; Methylphenidate; Norepinephrine Plasma Membrane Transport Proteins; Propylamines; Receptors, Adrenergic, alpha-2; Receptors, Dopamine D4; Receptors, Dopamine D5; Synaptosomal-Associated Protein 25	2010
A current update on ADHD pharmacogenomics. Pharmacogenomics, 2010, Volume: 11, Issue:3 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Catechol O-Methyltransferase; Central Nervous System Stimulants; Child; Dopamine Plasma Membrane Transport Proteins; Humans; Methylphenidate; Pharmacogenetics; Propylamines; Receptors, Adrenergic, alpha-2; Receptors, Dopamine D4	2010
Pharmacogenetic approach for a better drug treatment in children. Current pharmaceutical design, 2010, Volume: 16, Issue:22 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clinical Trials as Topic; Dopamine Plasma Membrane Transport Proteins; Humans; Methylphenidate; Pharmacogenetics; Polymorphism, Genetic; Propylamines; Receptors, Dopamine D4; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2010
Attention deficit hyperactivity disorder in adults. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2010, Volume: 11, Issue:5 Topics: Adrenergic Uptake Inhibitors; Adult; Age Factors; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Delayed-Action Preparations; Diagnosis, Differential; Drug Administration Schedule; Humans; Medication Adherence; Methylphenidate; Propylamines; Treatment Outcome	2010
Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder. Drug safety, 2010, Oct-01, Volume: 33, Issue:10 Topics: Adrenergic Uptake Inhibitors; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Central Nervous System Stimulants; Electrocardiography; Heart Rate; Humans; Methylphenidate; Propylamines	2010
Core ADHD symptom improvement with atomoxetine versus methylphenidate: a direct comparison meta-analysis. Journal of attention disorders, 2011, Volume: 15, Issue:8 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Female; Humans; Male; Methylphenidate; Propylamines; Randomized Controlled Trials as Topic; Treatment Outcome	2011
Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders. Developmental disabilities research reviews, 2010, Volume: 16, Issue:3 Topics: Adolescent; Amphetamines; Antipsychotic Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Child, Preschool; Clinical Trials as Topic; Clonidine; Comorbidity; Developmental Disabilities; Drug Therapy, Combination; Female; Fetal Alcohol Spectrum Disorders; Humans; Intellectual Disability; Male; Methylphenidate; Pregnancy; Propylamines; Psychotropic Drugs	2010
The neurobiological basis of ADHD. Italian journal of pediatrics, 2010, Dec-22, Volume: 36, Issue:1 Topics: Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Basal Ganglia; Behavior Therapy; Brain; Central Nervous System Stimulants; Cerebellum; Dopamine; Dopamine Agents; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Italy; Methylphenidate; Prefrontal Cortex; Propylamines; Risk Factors; Treatment Outcome	2010
Advances in the treatment of attention-deficit/hyperactivity disorder: a guide for pediatric neurologists. Seminars in pediatric neurology, 2010, Volume: 17, Issue:4 Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dextroamphetamine; Guanfacine; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Propylamines	2010
Pharmacotherapy for child and adolescent attention-deficit hyperactivity disorder. Pediatric clinics of North America, 2011, Volume: 58, Issue:1 Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Guanfacine; Humans; Methylphenidate; Propylamines	2011
How oppositionality, inattention, and hyperactivity affect response to atomoxetine versus methylphenidate: a pooled meta-analysis. Journal of attention disorders, 2012, Volume: 16, Issue:4 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Humans; Hyperkinesis; Methylphenidate; Propylamines; Treatment Outcome	2012
[Towards an understanding of the molecular mechanisms underlying the pharmacological treatments of attention deficit hyperactivity disorder]. Revista de neurologia, 2011, Mar-01, Volume: 52 Suppl 1 Topics: Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Humans; Methylphenidate; Norepinephrine; Prefrontal Cortex; Propylamines	2011
[Alcoholic foetopathy: an update]. Revista de neurologia, 2011, Mar-01, Volume: 52 Suppl 1 Topics: Adrenergic Uptake Inhibitors; Alcoholism; Atomoxetine Hydrochloride; Central Nervous System Stimulants; Cognition Disorders; Diagnosis, Differential; Female; Fetal Alcohol Spectrum Disorders; Humans; Methylphenidate; Nervous System Malformations; Pregnancy; Propylamines; Randomized Controlled Trials as Topic	2011
Catecholamine influences on dorsolateral prefrontal cortical networks. Biological psychiatry, 2011, Jun-15, Volume: 69, Issue:12 Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Animals; Arousal; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Catecholamines; Cognition; Guanfacine; Humans; Memory, Short-Term; Methylphenidate; Models, Neurological; Neural Pathways; Prefrontal Cortex; Propylamines; Synaptic Transmission	2011
[Effectiveness and safety of methylphenidate and atomoxetine for attention deficit hyperactivity disorder: a systematic review]. Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2011, Volume: 13, Issue:5 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Delayed-Action Preparations; Humans; Methylphenidate; Propylamines; Randomized Controlled Trials as Topic; Tablets	2011
Cognitive enhancers for the treatment of ADHD. Pharmacology, biochemistry, and behavior, 2011, Volume: 99, Issue:2 Topics: Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Cholinergic Agents; Clonidine; Cognition; Executive Function; Guanfacine; Humans; Intelligence; Methylphenidate; Nootropic Agents; Propylamines; Reward; Social Behavior	2011
[Stimulant and non-stimulant medication in current and future therapy for ADHD]. Fortschritte der Neurologie-Psychiatrie, 2012, Volume: 80, Issue:3 Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Central Nervous System Stimulants; Child; Dextroamphetamine; Fatty Acids, Omega-3; Guanfacine; Histamine Agonists; Humans; Isoxazoles; Lisdexamfetamine Dimesylate; Memantine; Methylphenidate; Modafinil; Off-Label Use; Propylamines; Pyridines; Pyrrolidines; Receptors, AMPA	2012
ADHD in children and adolescents. BMJ clinical evidence, 2011, Feb-04, Volume: 2011 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Humans; Methylphenidate; Schools	2011
Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis. BMC psychiatry, 2011, Nov-10, Volume: 11 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Humans; Methylphenidate; Propylamines; Treatment Outcome	2011
[Diagnosis and treatment of attention deficit hyperactivity disorder in adults]. Revista de neurologia, 2012, Feb-29, Volume: 54 Suppl 1 Topics: Adult; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Automobile Driving; Behavior Therapy; Bupropion; Central Nervous System Stimulants; Combined Modality Therapy; Comorbidity; Dextroamphetamine; Diagnostic Self Evaluation; Educational Status; Female; Humans; Interpersonal Relations; Interview, Psychological; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Neuropsychological Tests; Occupations; Propylamines; Quality of Life; Severity of Illness Index; Symptom Assessment	2012
Metabolic, toxicological, and safety considerations for drugs used to treat ADHD. Expert opinion on drug metabolism & toxicology, 2012, Volume: 8, Issue:5 Topics: Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Clinical Trials as Topic; Clonidine; Comorbidity; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Guanfacine; Humans; Methylphenidate; Propylamines	2012
Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: a review of controlled and naturalistic studies. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2013, Volume: 23, Issue:6 Topics: Adrenergic Uptake Inhibitors; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cross-Sectional Studies; Humans; Longitudinal Studies; Methylphenidate; Propylamines; Randomized Controlled Trials as Topic	2013
Pharmacological and clinical dilemmas of prescribing in co-morbid adult attention-deficit/hyperactivity disorder and addiction. British journal of clinical pharmacology, 2014, Volume: 77, Issue:2 Topics: Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Combined Modality Therapy; Diagnosis, Dual (Psychiatry); Humans; Methylphenidate; Practice Patterns, Physicians'; Propylamines; Psychotherapy; Substance-Related Disorders	2014
Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents. Journal of child psychology and psychiatry, and allied disciplines, 2013, Volume: 54, Issue:3 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Body Size; Cardiovascular Diseases; Central Nervous System Stimulants; Child; Clonidine; Dextroamphetamine; Growth Disorders; Guanfacine; Heart Rate; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Propylamines; Psychoses, Substance-Induced; Seizures; Sleep Wake Disorders; Substance-Related Disorders; Suicide Prevention; Tic Disorders; Treatment Outcome	2013
Toward quality care in ADHD: defining the goals of treatment. Journal of attention disorders, 2015, Volume: 19, Issue:2 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Goals; Guanfacine; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Propylamines; Quality of Health Care; Treatment Outcome	2015
Systematic review of atomoxetine data in childhood and adolescent attention-deficit hyperactivity disorder 2009-2011: focus on clinical efficacy and safety. Journal of psychopharmacology (Oxford, England), 2014, Volume: 28, Issue:3 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Humans; Methylphenidate; Propylamines; Treatment Outcome	2014
[Bases for the selection of pharmacological treatment in attention deficit hyperactivity disorder]. Revista de neurologia, 2013, Feb-22, Volume: 56 Suppl 1 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Drug Prescriptions; Humans; Methylphenidate; Practice Guidelines as Topic; Propylamines	2013
Systematic review and meta-analysis of pharmacological treatment of the symptoms of attention-deficit/hyperactivity disorder in children with pervasive developmental disorders. Journal of autism and developmental disorders, 2013, Volume: 43, Issue:10 Topics: Adolescent; Atomoxetine Hydrochloride; Attention; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Child, Preschool; Double-Blind Method; Female; Humans; Methylphenidate; Propylamines; Randomized Controlled Trials as Topic	2013
Attention deficit hyperactivity disorder in the European adult population: prevalence, disease awareness, and treatment guidelines. Current medical research and opinion, 2013, Volume: 29, Issue:9 Topics: Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Europe; Female; Humans; Male; Methylphenidate; Practice Guidelines as Topic; Prevalence; Propylamines; Randomized Controlled Trials as Topic; Retrospective Studies	2013
[The practice and problem of therapeutic agents for AD/HD]. No to hattatsu = Brain and development, 2010, Volume: 42, Issue:3 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Humans; Japan; Methylphenidate; Propylamines; Treatment Outcome	2010
[Autism and attention deficit hyperactivity disorder: pharmacological intervention]. Revista de neurologia, 2013, Sep-06, Volume: 57 Suppl 1 Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Clonidine; Dopamine Uptake Inhibitors; Drug Evaluation; Guanfacine; Humans; Methylphenidate; Neuroimaging; Propylamines; Psychotropic Drugs; Randomized Controlled Trials as Topic; Treatment Outcome	2013
Current pharmacotherapy of attention deficit hyperactivity disorder. Drugs of today (Barcelona, Spain : 1998), 2013, Volume: 49, Issue:10 Topics: Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; Humans; Methylphenidate; Propylamines	2013
A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD). The Annals of pharmacotherapy, 2014, Volume: 48, Issue:2 Topics: Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Drug Interactions; Humans; Methylphenidate; Propylamines	2014
Systematic evidence synthesis of treatments for ADHD in children and adolescents: indirect treatment comparisons of lisdexamfetamine with methylphenidate and atomoxetine. Current medical research and opinion, 2014, Volume: 30, Issue:8 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dextroamphetamine; Dopamine Uptake Inhibitors; Europe; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Models, Statistical; Propylamines; Treatment Outcome	2014
Pharmacological and psychosocial treatments for adolescents with ADHD: an updated systematic review of the literature. Clinical psychology review, 2014, Volume: 34, Issue:3 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; Combined Modality Therapy; Humans; Methylphenidate; Propylamines; Treatment Outcome	2014
Safety of medicines used for ADHD in children: a review of published prospective clinical trials. Archives of disease in childhood, 2014, Volume: 99, Issue:9 Topics: Adolescent; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Humans; Methylphenidate; Propylamines; Prospective Studies; Treatment Outcome	2014
Priapism associated with the use of stimulant medications and atomoxetine for attention-deficit/hyperactivity disorder in children. The Annals of pharmacotherapy, 2014, Volume: 48, Issue:10 Topics: Adrenergic Uptake Inhibitors; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Humans; Male; Methylphenidate; Priapism; Propylamines	2014
Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder: an update. Drug safety, 2014, Volume: 37, Issue:9 Topics: Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Central Nervous System Stimulants; Death, Sudden, Cardiac; Heart Rate; Humans; Methylphenidate; Propylamines	2014
Brain abnormalities in attention-deficit hyperactivity disorder: a review. Revista de neurologia, 2014, Feb-24, Volume: 58 Suppl 1 Topics: Adolescent; Adult; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Brain; Brain Mapping; Central Nervous System Stimulants; Child; Clinical Trials as Topic; Conduct Disorder; Diagnosis, Differential; Humans; Magnetic Resonance Imaging; Methylphenidate; Nerve Net; Neuroimaging; Neuroprotective Agents; Positron-Emission Tomography; White Matter	2014
Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropion. Journal of affective disorders, 2015, Jun-01, Volume: 178 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Comparative Effectiveness Research; Dextroamphetamine; Double-Blind Method; Female; Humans; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Patient Acceptance of Health Care; Propylamines; Randomized Controlled Trials as Topic; Treatment Outcome	2015
Long-Term Pharmacotherapy of Adults With Attention Deficit Hyperactivity Disorder: A Literature Review and Clinical Study. Basic & clinical pharmacology & toxicology, 2016, Volume: 118, Issue:1 Topics: Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Databases, Factual; Humans; Methylphenidate; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome	2016
Are there any potentially dangerous pharmacological effects of combining ADHD medication with alcohol and drugs of abuse? A systematic review of the literature. BMC psychiatry, 2015, Oct-30, Volume: 15 Topics: Adolescent; Adrenergic Uptake Inhibitors; Alcohol Drinking; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Drug Interactions; Humans; Illicit Drugs; Lisdexamfetamine Dimesylate; Methylphenidate; Substance-Related Disorders	2015
A network meta-analysis of atomoxetine and osmotic release oral system methylphenidate in the treatment of attention-deficit/hyperactivity disorder in adult patients. Journal of psychopharmacology (Oxford, England), 2016, Volume: 30, Issue:5 Topics: Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Humans; Methylphenidate; Network Meta-Analysis	2016
Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review. JAMA, 2016, May-10, Volume: 315, Issue:18 Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Clonidine; Delayed-Action Preparations; Guanfacine; Humans; Methylphenidate; Motivation; Psychotherapy; Randomized Controlled Trials as Topic; Social Skills	2016
An Evaluation on the Efficacy and Safety of Treatments for Attention Deficit Hyperactivity Disorder in Children and Adolescents: a Comparison of Multiple Treatments. Molecular neurobiology, 2017, Volume: 54, Issue:9 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Dextroamphetamine; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Treatment Outcome	2017
Current and Investigational Medication Delivery Systems for Treating Attention-Deficit/Hyperactivity Disorder. The primary care companion for CNS disorders, 2016, Aug-18, Volume: 18, Issue:4 Topics: Adrenergic Agents; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Clinical Trials as Topic; Clonidine; Guanfacine; Humans; Methylphenidate; Treatment Outcome	2016
Optimizing outcomes in ADHD treatment: from clinical targets to novel delivery systems. CNS spectrums, 2016, Volume: 21, Issue:S1 Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous System Stimulants; Clonidine; Comorbidity; Delayed-Action Preparations; Depressive Disorder; Dextroamphetamine; Guanfacine; Humans; Methylphenidate	2016
Comparative efficacy and safety of methylphenidate and atomoxetine for attention-deficit hyperactivity disorder in children and adolescents: Meta-analysis based on head-to-head trials. Journal of clinical and experimental neuropsychology, 2017, Volume: 39, Issue:9 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Female; Humans; Male; Methylphenidate; Treatment Outcome	2017
Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine. CNS drugs, 2017, Volume: 31, Issue:3 Topics: Adolescent; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Central Nervous System Stimulants; Child; Child, Preschool; Clinical Trials as Topic; Heart Rate; Humans; Infant; Methylphenidate; Psychotropic Drugs	2017
Safety of Treatments for ADHD in Adults: Pairwise and Network Meta-Analyses. Journal of attention disorders, 2019, Volume: 23, Issue:2 Topics: Adrenergic Uptake Inhibitors; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Databases, Factual; Humans; Methylphenidate; Network Meta-Analysis; Odds Ratio; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Wakefulness	2019
Discontinuation of pharmacological treatment of children and adolescents with attention deficit hyperactivity disorder: meta-analysis of 63 studies enrolling 11,788 patients. Psychopharmacology, 2017, Volume: 234, Issue:17 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Female; Humans; Male; Methylphenidate; Treatment Outcome; Withholding Treatment	2017
Effects of stimulants and atomoxetine on emotional lability in adults: A systematic review and meta-analysis. European psychiatry : the journal of the Association of European Psychiatrists, 2017, Volume: 44 Topics: Adult; Affective Symptoms; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Emotions; Female; Humans; Methylphenidate; Middle Aged; Mood Disorders; Young Adult	2017
Pharmacotherapy of emotional dysregulation in adults with ADHD: A systematic review and meta-analysis. Neuroscience and biobehavioral reviews, 2018, Volume: 84 Topics: Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Emotions; Humans; Methylphenidate	2018
Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology. Journal of psychopharmacology (Oxford, England), 2018, Volume: 32, Issue:1 Topics: Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Brain; Consensus; Guanfacine; Humans; Melatonin; Methylphenidate; Psychopharmacology; Sleep Wake Disorders	2018
Clinical trials in autism spectrum disorder: evidence, challenges and future directions. Current opinion in neurology, 2018, Volume: 31, Issue:2 Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Aggression; Antipsychotic Agents; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Central Nervous System Depressants; Central Nervous System Stimulants; Clinical Trials as Topic; Evidence-Based Medicine; Humans; Hypoglycemic Agents; Irritable Mood; Melatonin; Metformin; Methylphenidate; Obesity; Outcome Assessment, Health Care; Precision Medicine; Risperidone; Sleep; Sleep Wake Disorders	2018
Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders. The Cochrane database of systematic reviews, 2018, 06-26, Volume: 6 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Clonidine; Desipramine; Dextroamphetamine; Female; Guanfacine; Humans; Male; Methylphenidate; Randomized Controlled Trials as Topic; Selegiline; Tic Disorders	2018
The Effect of Methylphenidate and Atomoxetine on Heart Rate and Systolic Blood Pressure in Young People and Adults with Attention-Deficit Hyperactivity Disorder (ADHD): Systematic Review, Meta-Analysis, and Meta-Regression. International journal of environmental research and public health, 2018, 08-20, Volume: 15, Issue:8 Topics: Adolescent; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Central Nervous System Stimulants; Child; Heart Rate; Humans; Methylphenidate	2018
Light up ADHD: II. Neuropharmacological effects measured by near infrared spectroscopy: is there a biomarker? Journal of affective disorders, 2019, 02-01, Volume: 244 Topics: Aging; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Biomarkers; Humans; Methylphenidate; Oxyhemoglobins; Prefrontal Cortex; Spectroscopy, Near-Infrared	2019
Pharmacological treatment of attention-deficit hyperactivity disorder comorbid with an anxiety disorder: a systematic review. International clinical psychopharmacology, 2019, Volume: 34, Issue:2 Topics: Adolescent; Adult; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Agents; Child; Comorbidity; Desipramine; Double-Blind Method; Female; Fluvoxamine; Humans; Male; Methylphenidate; Randomized Controlled Trials as Topic; Treatment Outcome	2019
Systematic review and exploratory meta-analysis of the efficacy, safety, and biological effects of psychostimulants and atomoxetine in patients with schizophrenia or schizoaffective disorder. CNS spectrums, 2019, Volume: 24, Issue:5 Topics: Amphetamines; Antipsychotic Agents; Atomoxetine Hydrochloride; Attention; Executive Function; Humans; Memory, Short-Term; Methylphenidate; Problem Solving; Psychotic Disorders; Schizophrenia	2019
Pharmacotherapy for Hoarding Disorder: How did the Picture Change since its Excision from OCD? Current neuropharmacology, 2019, Volume: 17, Issue:8 Topics: Atomoxetine Hydrochloride; Hoarding Disorder; Humans; Methylphenidate; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors	2019
Using Cell Cultures for the Investigation of Treatments for Attention Deficit Hyperactivity Disorder: A Systematic Review. Current neuropharmacology, 2019, Volume: 17, Issue:10 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Cell Culture Techniques; Cells, Cultured; Central Nervous System Stimulants; Child; Humans; Methylphenidate; Neurons	2019
[Adult attention deficit hyperactivity disorder (ADHD) with comorbid addictive disorder. Therapeutic challenges using the example of a survey of clinical practice]. MMW Fortschritte der Medizin, 2019, Volume: 161, Issue:Suppl 5 Topics: Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Humans; Methylphenidate; Substance-Related Disorders; Surveys and Questionnaires	2019
Relationship Between Treatment Duration and Efficacy of Pharmacological Treatment for ADHD: A Meta-Analysis and Meta-Regression of 87 Randomized Controlled Clinical Trials. Journal of attention disorders, 2021, Volume: 25, Issue:10 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Duration of Therapy; Humans; Methylphenidate; Randomized Controlled Trials as Topic; Treatment Outcome	2021
[Attention deficit hyperactivity disorder in childhood and adolescence : Current state of research]. Der Nervenarzt, 2020, Volume: 91, Issue:7 Topics: Adolescent; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Germany; Humans; Methylphenidate	2020
Clinical guidance on pharmacotherapy for the treatment of attention-deficit hyperactivity disorder (ADHD) for people with intellectual disability. Expert opinion on pharmacotherapy, 2020, Volume: 21, Issue:15 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Cognition; Dextroamphetamine; Humans; Intellectual Disability; Methylphenidate; Practice Guidelines as Topic; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome	2020
Practitioner Review: Pharmacological treatment of attention-deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis. Journal of child psychology and psychiatry, and allied disciplines, 2021, Volume: 62, Issue:6 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Central Nervous System Stimulants; Child; Guanfacine; Humans; Methylphenidate	2021
Pharmacologic Treatment of Attention Deficit-Hyperactivity Disorder. The New England journal of medicine, 2020, 09-10, Volume: 383, Issue:11 Topics: Adolescent; Adult; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Growth; Guanfacine; Heart Rate; Humans; Hypertension; Methylphenidate; Patient Dropouts; Polymers; Practice Guidelines as Topic; Treatment Outcome	2020
The female side of pharmacotherapy for ADHD-A systematic literature review. PloS one, 2020, Volume: 15, Issue:9 Topics: Adolescent; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Databases, Factual; Drug Prescriptions; Female; Humans; Male; Men; Methylphenidate; Sex Characteristics; Young Adult	2020
Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis. PloS one, 2020, Volume: 15, Issue:10 Topics: Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bayes Theorem; Bupropion; Central Nervous System Stimulants; Dextroamphetamine; Drug-Related Side Effects and Adverse Reactions; Female; Guanfacine; Humans; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Modafinil; Network Meta-Analysis; Quality of Life; Randomized Controlled Trials as Topic	2020
Systematic Review: Medication Effects on Brain Intrinsic Functional Connectivity in Patients With Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 2021, Volume: 60, Issue:2 Topics: Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain; Central Nervous System Stimulants; Child; Female; Humans; Magnetic Resonance Imaging; Methylphenidate; Reproducibility of Results	2021
Pharmacotherapy of attention deficit/hyperactivity disorder in individuals with autism spectrum disorder: A systematic review of the literature. Journal of psychopharmacology (Oxford, England), 2021, Volume: 35, Issue:3 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Guanfacine; Humans; Intellectual Disability; Methylphenidate; Treatment Outcome	2021
Clinical practice guideline on pharmacological and psychological management of adult patients with attention deficit and hyperactivity disorder and comorbid substance use. Adicciones, 2022, Apr-01, Volume: 34, Issue:2 Topics: Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cocaine; Comorbidity; Humans; Methylphenidate; Substance-Related Disorders	2022
Evidence-based pharmacological treatment options for ADHD in children and adolescents. Pharmacology & therapeutics, 2022, Volume: 230 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cross-Sectional Studies; Humans; Methylphenidate	2022
A Practical, Evidence-informed Approach to Managing Stimulant-Refractory Attention Deficit Hyperactivity Disorder (ADHD). CNS drugs, 2021, Volume: 35, Issue:10 Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Clonidine; Dextroamphetamine; Drug Resistance; Empirical Research; Humans; Methylphenidate; Randomized Controlled Trials as Topic	2021
Editorial: Accumulating Evidence for the Benefit of Micronutrients for Children With Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 2022, Volume: 61, Issue:5 Topics: Adolescent; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Humans; Methylphenidate; Micronutrients	2022
Headache in ADHD as comorbidity and a side effect of medications: a systematic review and meta-analysis. Psychological medicine, 2022, Volume: 52, Issue:1 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Comorbidity; Drug-Related Side Effects and Adverse Reactions; Guanfacine; Headache; Humans; Methylphenidate; Randomized Controlled Trials as Topic	2022
Association between central nervous system stimulants used to treat attention deficit hyperactivity disorder (ADHD) and Raynaud's phenomenon: A scoping review. Seminars in arthritis and rheumatism, 2021, Volume: 51, Issue:6 Topics: Adolescent; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Humans; Methylphenidate; Raynaud Disease	2021
Current Pharmacological Treatments for ADHD. Current topics in behavioral neurosciences, 2022, Volume: 57 Topics: Adolescent; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Drug-Related Side Effects and Adverse Reactions; Humans; Methylphenidate; Quality of Life	2022
Do Treatments for Adult ADHD Improve Emotional Behavior? A Systematic Review and Analysis. Journal of attention disorders, 2022, Volume: 26, Issue:14 Topics: Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Treatment Outcome	2022
Treatments for child and adolescent attention deficit hyperactivity disorder in low and middle-income countries: A narrative review. Asian journal of psychiatry, 2022, Volume: 76 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Clonidine; Developing Countries; Humans; Methylphenidate	2022
Therapeutic Approaches for ADHD by Developmental Stage and Clinical Presentation. International journal of environmental research and public health, 2022, 10-08, Volume: 19, Issue:19 Topics: Adolescent; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Guanfacine; Humans; Methylphenidate	2022
Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents. The Cochrane database of systematic reviews, 2023, 04-14, Volume: 4 Topics: Adolescent; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Fatty Acids, Omega-3; Fatty Acids, Unsaturated; Humans; Methylphenidate; Quality of Life	2023
Association between sleep pattern and pharmacological treatment in children with attention deficit disorder with hyperactivity: a systematic review. Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo, 2023, Volume: 41 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Humans; Methylphenidate; Sleep	2023

Trials

58 trial(s) available for atomoxetine hydrochloride and methylphenidate

Article	Year
Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users. Drug and alcohol dependence, 2002, Jul-01, Volume: 67, Issue:2 Topics: Adolescent; Adult; Analysis of Variance; Atomoxetine Hydrochloride; Blood Pressure; Double-Blind Method; Female; Humans; Least-Squares Analysis; Male; Methylphenidate; Outcome Assessment, Health Care; Propylamines; Psychomotor Performance; Substance-Related Disorders	2002
Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial. Journal of the American Academy of Child and Adolescent Psychiatry, 2002, Volume: 41, Issue:7 Topics: Adolescent; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Female; Humans; Male; Methylphenidate; Propylamines; Prospective Studies	2002
Pharmacotherapy of adult ADHD. Journal of clinical psychology, 2005, Volume: 61, Issue:5 Topics: Adolescent; Adult; Age Factors; Amphetamine; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; Child; Combined Modality Therapy; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Methylphenidate; Propylamines; Treatment Outcome	2005
Hemodynamic effects of acute administration of atomoxetine and methylphenidate. Journal of clinical pharmacology, 2005, Volume: 45, Issue:7 Topics: Adrenergic Agents; Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Blood Pressure; Cross-Over Studies; Double-Blind Method; Epinephrine; Heart Rate; Humans; Male; Methylphenidate; Norepinephrine; Propylamines	2005
Comparison of the inhibitory and excitatory effects of ADHD medications methylphenidate and atomoxetine on motor cortex. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2006, Volume: 31, Issue:2 Topics: Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Cross-Over Studies; Double-Blind Method; Evoked Potentials, Motor; Female; Humans; Male; Meta-Analysis as Topic; Methylphenidate; Motor Cortex; Neural Inhibition; Propylamines; Time Factors; Transcranial Magnetic Stimulation	2006
Multicenter, randomized, open-label study of OROS methylphenidate versus atomoxetine: treatment outcomes in African-American children with ADHD. Journal of the National Medical Association, 2005, Volume: 97, Issue:10 Suppl Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Female; Humans; Male; Methylphenidate; Propylamines; Treatment Outcome	2005
Dopamine transporter genotype influences the physiological response to medication in ADHD. Brain : a journal of neurology, 2006, Volume: 129, Issue:Pt 8 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cross-Over Studies; Dopamine Plasma Membrane Transport Proteins; Double-Blind Method; Female; Genotype; Humans; Male; Methylphenidate; Motor Cortex; Neural Inhibition; Pharmacogenetics; Phenotype; Propylamines; Tourette Syndrome; Treatment Outcome	2006
Attention-deficit/hyperactivity disorder: use of cognitive evoked potential (P300) to predict treatment response. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 2006, Volume: 117, Issue:9 Topics: Acoustic Stimulation; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain Mapping; Cerebral Cortex; Child; Cross-Over Studies; Double-Blind Method; Electroencephalography; Event-Related Potentials, P300; Female; Functional Laterality; Humans; Male; Methylphenidate; Predictive Value of Tests; Propylamines; Reference Values; ROC Curve	2006
Meta-analysis of aggression or hostility events in randomized, controlled clinical trials of atomoxetine for ADHD. Biological psychiatry, 2007, Mar-01, Volume: 61, Issue:5 Topics: Adolescent; Adrenergic Uptake Inhibitors; Aged; Aggression; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Databases as Topic; Double-Blind Method; Female; Hostility; Humans; Male; Methylphenidate; Middle Aged; Odds Ratio; Proportional Hazards Models; Propylamines	2007
Effects of atomoxetine and methylphenidate on sleep in children with ADHD. Sleep, 2006, Volume: 29, Issue:12 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrophysiology; Female; Humans; Male; Methylphenidate; Propylamines; Sleep, REM	2006
A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD). Current medical research and opinion, 2007, Volume: 23, Issue:2 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Drug Therapy, Combination; Female; Headache; Humans; Male; Methylphenidate; Nausea; Propylamines; Prospective Studies; Severity of Illness Index; Treatment Outcome	2007
A pharmacological analysis of stimulant-induced increases in smoking. Psychopharmacology, 2007, Volume: 193, Issue:3 Topics: Adrenergic Uptake Inhibitors; Adult; Analysis of Variance; Atomoxetine Hydrochloride; Blood Pressure; Central Nervous System Stimulants; Eating; Female; Humans; Male; Methylphenidate; Propylamines; Smoking; Surveys and Questionnaires	2007
Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial. The Australian and New Zealand journal of psychiatry, 2007, Volume: 41, Issue:3 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Central Nervous System Stimulants; Child; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Methylphenidate; Personality Assessment; Propylamines	2007
Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study. Clinical therapeutics, 2007, Volume: 29, Issue:6 Topics: Adolescent; Adrenergic Uptake Inhibitors; Amphetamine; Analysis of Variance; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Central Nervous System Stimulants; Child; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Heart Rate; Humans; Male; Methylphenidate; Pilot Projects; Propylamines; Severity of Illness Index; Treatment Outcome	2007
Medications do not necessarily normalize cognition in ADHD patients. Journal of attention disorders, 2008, Volume: 11, Issue:4 Topics: Adrenergic Uptake Inhibitors; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cognition; Cross-Sectional Studies; Female; Humans; Male; Methylphenidate; Neuropsychological Tests; Propylamines	2008
Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response. The American journal of psychiatry, 2008, Volume: 165, Issue:6 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Central Nervous System Stimulants; Child; Cross-Over Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Methylphenidate; Personality Assessment; Propylamines; Treatment Outcome	2008
Abuse liability assessment of atomoxetine in a drug-abusing population. Drug and alcohol dependence, 2008, May-01, Volume: 95, Issue:1-2 Topics: Adrenergic Uptake Inhibitors; Adult; Arousal; Atomoxetine Hydrochloride; Central Nervous System Stimulants; Cross-Over Studies; Desipramine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Methylphenidate; Middle Aged; Pain Measurement; Phentermine; Propylamines; Risk; Substance-Related Disorders	2008
Long-term, open-label safety and efficacy of atomoxetine in adults with ADHD: final report of a 4-year study. Journal of attention disorders, 2008, Volume: 12, Issue:3 Topics: Adrenergic Uptake Inhibitors; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Humans; Longitudinal Studies; Methylphenidate; Patient Dropouts; Placebos; Propylamines; Psychiatric Status Rating Scales; Safety; Severity of Illness Index; Treatment Outcome	2008
An open study of adjunct OROS-methylphenidate in children and adolescents who are atomoxetine partial responders: I. Effectiveness. Journal of child and adolescent psychopharmacology, 2009, Volume: 19, Issue:5 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Male; Methylphenidate; Propylamines; Severity of Illness Index; Treatment Outcome	2009
An open study of adjunct OROS-methylphenidate in children who are atomoxetine partial responders: II. Tolerability and pharmacokinetics. Journal of child and adolescent psychopharmacology, 2009, Volume: 19, Issue:5 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Drug Therapy, Combination; Electrocardiography; Female; Heart Rate; Humans; Liver Function Tests; Male; Methylphenidate; Propylamines	2009
Does placebo response differ between objective and subjective measures in children with attention-deficit/hyperactivity disorder? Postgraduate medicine, 2010, Volume: 122, Issue:5 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Humans; Male; Methylphenidate; Neuropsychological Tests; Placebo Effect; Propylamines; Severity of Illness Index	2010
Atomoxetine and methylphenidate treatment in children with ADHD: the efficacy, tolerability and effects on executive functions. Child psychiatry and human development, 2011, Volume: 42, Issue:3 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Executive Function; Female; Humans; Male; Methylphenidate; Neuropsychological Tests; Propylamines; Treatment Outcome	2011
Methylphenidate but not atomoxetine or citalopram modulates inhibitory control and response time variability. Biological psychiatry, 2011, May-01, Volume: 69, Issue:9 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Citalopram; Cross-Over Studies; Dopamine Uptake Inhibitors; Double-Blind Method; Humans; Inhibition, Psychological; Male; Methylphenidate; Neuropsychological Tests; Propylamines; Reaction Time; Selective Serotonin Reuptake Inhibitors	2011
Pattern classification of working memory networks reveals differential effects of methylphenidate, atomoxetine, and placebo in healthy volunteers. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2011, Volume: 36, Issue:6 Topics: Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Central Nervous System Stimulants; Humans; Magnetic Resonance Imaging; Male; Memory, Short-Term; Methylphenidate; Neuropsychological Tests; Placebo Effect; Propylamines; Reward; Task Performance and Analysis; Young Adult	2011
One-year prospective follow-up of pharmacological treatment in children with attention-deficit/hyperactivity disorder. European journal of clinical pharmacology, 2011, Volume: 67, Issue:10 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cohort Studies; Follow-Up Studies; Humans; Male; Methylphenidate; Propylamines; Prospective Studies	2011
Comparative study of OROS-MPH and atomoxetine on executive function improvement in ADHD: a randomized controlled trial. The international journal of neuropsychopharmacology, 2012, Volume: 15, Issue:1 Topics: Administration, Oral; Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Executive Function; Female; Humans; Male; Memory, Short-Term; Methylphenidate; Neuropsychological Tests; Propylamines; Treatment Outcome	2012
Neurochemical enhancement of conscious error awareness. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012, Feb-22, Volume: 32, Issue:8 Topics: Adolescent; Adult; Analysis of Variance; Atomoxetine Hydrochloride; Awareness; Brain Mapping; Central Nervous System Stimulants; Citalopram; Consciousness; Cross-Over Studies; Double-Blind Method; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Inhibition, Psychological; Magnetic Resonance Imaging; Male; Methylphenidate; Neuropsychological Tests; Oxygen; Parietal Lobe; Photic Stimulation; Propylamines; Reaction Time; Time Factors; Young Adult	2012
Randomized clinical study of a histamine H3 receptor antagonist for the treatment of adults with attention-deficit hyperactivity disorder. CNS drugs, 2012, May-01, Volume: 26, Issue:5 Topics: Administration, Oral; Adolescent; Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Benzamides; Central Nervous System Stimulants; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Histamine H3 Antagonists; Humans; Male; Methylphenidate; Middle Aged; Piperazines; Propylamines; Treatment Outcome; Wakefulness; Young Adult	2012
Social-skills and parental training plus standard treatment versus standard treatment for children with ADHD--the randomised SOSTRA trial. PloS one, 2012, Volume: 7, Issue:6 Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Dextroamphetamine; Dopamine Uptake Inhibitors; Female; Humans; Male; Methylphenidate; Parents; Propylamines; Social Behavior	2012
Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder. Archives of general psychiatry, 2012, Volume: 69, Issue:9 Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain; Brain Mapping; Central Nervous System Stimulants; Child; Female; Frontal Lobe; Gyrus Cinguli; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Inhibition, Psychological; Magnetic Resonance Imaging; Male; Methylphenidate; Motor Cortex; Neural Pathways; Neuropsychological Tests; Parietal Lobe; Propylamines; Psychomotor Performance; Treatment Outcome	2012
Shared and drug-specific effects of atomoxetine and methylphenidate on inhibitory brain dysfunction in medication-naive ADHD boys. Cerebral cortex (New York, N.Y. : 1991), 2014, Volume: 24, Issue:1 Topics: Adolescent; Adrenergic Uptake Inhibitors; Analysis of Variance; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain; Case-Control Studies; Catecholamines; Central Nervous System Stimulants; Child; Cross-Over Studies; Data Interpretation, Statistical; Double-Blind Method; Humans; Image Processing, Computer-Assisted; Inhibition, Psychological; Intelligence Tests; Magnetic Resonance Imaging; Male; Methylphenidate; Movement; Neuropsychological Tests; Prefrontal Cortex; Propylamines; Psychomotor Performance	2014
An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Adults With ADHD. Journal of attention disorders, 2017, Volume: 21, Issue:1 Topics: Adolescent; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Medication Adherence; Methylphenidate; Middle Aged; Psychiatric Status Rating Scales; Quality of Life; Treatment Outcome; Young Adult	2017
Drug-specific laterality effects on frontal lobe activation of atomoxetine and methylphenidate in attention deficit hyperactivity disorder boys during working memory. Psychological medicine, 2014, Volume: 44, Issue:3 Topics: Adolescent; Analysis of Variance; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Basal Ganglia; Brain Mapping; Child; Cross-Over Studies; Double-Blind Method; Frontal Lobe; Functional Laterality; Humans; Magnetic Resonance Imaging; Male; Memory, Short-Term; Methylphenidate; Neuropsychological Tests; Neurotransmitter Uptake Inhibitors; Placebos; Prefrontal Cortex; Propylamines	2014
A head-to-head randomized clinical trial of methylphenidate and atomoxetine treatment for executive function in adults with attention-deficit hyperactivity disorder. The international journal of neuropsychopharmacology, 2013, Volume: 16, Issue:9 Topics: Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Attention; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Chi-Square Distribution; Dopamine Uptake Inhibitors; Executive Function; Female; Humans; Linear Models; Male; Memory, Short-Term; Methylphenidate; Neuropsychological Tests; Propylamines; Taiwan; Time Factors; Treatment Outcome; Visual Perception	2013
Neurofunctional effects of methylphenidate and atomoxetine in boys with attention-deficit/hyperactivity disorder during time discrimination. Biological psychiatry, 2013, Oct-15, Volume: 74, Issue:8 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain; Brain Mapping; Cross-Over Studies; Discrimination, Psychological; Double-Blind Method; Humans; Magnetic Resonance Imaging; Male; Methylphenidate; Prefrontal Cortex; Propylamines; Time Factors	2013
Long-term quality-of-life and functioning comparison of atomoxetine versus other standard treatment in pediatric attention-deficit/hyperactivity disorder. Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:6 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Methylphenidate; Propylamines; Quality of Life; Time Factors; Treatment Outcome	2013
Monoaminergic modulation of behavioural and electrophysiological indices of error processing. Psychopharmacology, 2014, Volume: 231, Issue:2 Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Citalopram; Cross-Over Studies; Dopamine Uptake Inhibitors; Double-Blind Method; Evoked Potentials; Executive Function; Female; Humans; Male; Methylphenidate; Neuropsychological Tests; Propylamines; Psychomotor Performance; Reaction Time; Selective Serotonin Reuptake Inhibitors; Young Adult	2014
Dissociable and common effects of methylphenidate, atomoxetine and citalopram on response inhibition neural networks. Neuropsychologia, 2014, Volume: 56 Topics: Adolescent; Adult; Atomoxetine Hydrochloride; Awareness; Brain; Citalopram; Double-Blind Method; Executive Function; Humans; Image Processing, Computer-Assisted; Inhibition, Psychological; Magnetic Resonance Imaging; Male; Methylphenidate; Neural Pathways; Neuropsychological Tests; Neurotransmitter Agents; Oxygen; Propylamines; Visual Analog Scale; Young Adult	2014
Differential impact of methylphenidate and atomoxetine on sustained attention in youth with attention-deficit/hyperactivity disorder. Journal of child psychology and psychiatry, and allied disciplines, 2015, Volume: 56, Issue:1 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cross-Over Studies; Double-Blind Method; Executive Function; Female; Humans; Inhibition, Psychological; Male; Methylphenidate; Propylamines; Psychomotor Performance; Treatment Outcome	2015
Comparative short term efficacy and tolerability of methylphenidate and atomoxetine in attention deficit hyperactivity disorder. Indian pediatrics, 2014, Volume: 51, Issue:7 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Child Behavior; Female; Humans; Male; Methylphenidate; Propylamines	2014
Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidate. European child & adolescent psychiatry, 2016, Volume: 25, Issue:2 Topics: Adolescent; Atomoxetine Hydrochloride; Attention; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Treatment Outcome	2016
Pharmacotherapy of the Preschool ADHD Treatment Study (PATS) Children Growing Up. Journal of the American Academy of Child and Adolescent Psychiatry, 2015, Volume: 54, Issue:7 Topics: Antipsychotic Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Comorbidity; Female; Follow-Up Studies; Humans; Logistic Models; Male; Methylphenidate; Prospective Studies; Psychiatric Status Rating Scales; Treatment Outcome	2015
Effects of Atomoxetine and Osmotic Release Oral System-Methylphenidate on Executive Functions in Patients with Combined Type Attention-Deficit/Hyperactivity Disorder. Journal of child and adolescent psychopharmacology, 2015, Volume: 25, Issue:6 Topics: Administration, Oral; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cognition; Executive Function; Female; Humans; Male; Methylphenidate; Neuropsychological Tests; Osmosis; Prospective Studies; Psychiatric Status Rating Scales; Treatment Outcome	2015
An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder. Journal of child and adolescent psychopharmacology, 2015, Volume: 25, Issue:7 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Female; Humans; Male; Medication Adherence; Methylphenidate; Psychiatric Status Rating Scales; Treatment Outcome	2015
Safety of Methylphenidate and Atomoxetine in Children with Attention-Deficit/Hyperactivity Disorder (ADHD): Data from the Italian National ADHD Registry. CNS drugs, 2015, Volume: 29, Issue:10 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Comorbidity; Female; Humans; Incidence; Italy; Male; Methylphenidate; Psychiatric Status Rating Scales; Psychotropic Drugs; Registries; Severity of Illness Index	2015
Anxiety reduction on atomoxetine and methylphenidate medication in children with ADHD. Pediatrics international : official journal of the Japan Pediatric Society, 2016, Volume: 58, Issue:6 Topics: Adolescent; Adrenergic Uptake Inhibitors; Anxiety; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Methylphenidate; Retrospective Studies; Treatment Outcome	2016
Osmotic Release Oral System Methylphenidate Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Chinese Youth: 8-Week Comparative Efficacy and 1-Year Follow-Up. Journal of child and adolescent psychopharmacology, 2016, Volume: 26, Issue:4 Topics: Administration, Oral; Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Drug Liberation; Female; Follow-Up Studies; Humans; Male; Medication Adherence; Methylphenidate; Osmosis; Time Factors; Treatment Outcome	2016
Atomoxetine could improve intra-individual variability in drug-naïve adults with attention-deficit/hyperactivity disorder comparably with methylphenidate: A head-to-head randomized clinical trial. Journal of psychopharmacology (Oxford, England), 2016, Volume: 30, Issue:5 Topics: Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Female; Humans; Male; Methylphenidate; Reaction Time	2016
Is emotion recognition the only problem in ADHD? effects of pharmacotherapy on face and emotion recognition in children with ADHD. Attention deficit and hyperactivity disorders, 2016, Volume: 8, Issue:4 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Case-Control Studies; Central Nervous System Stimulants; Child; Emotions; Facial Expression; Female; Humans; Male; Methylphenidate; Recognition, Psychology; Sex Factors	2016
Effectiveness of atomoxetine and methylphenidate for problematic online gaming in adolescents with attention deficit hyperactivity disorder. Human psychopharmacology, 2016, Volume: 31, Issue:6 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior, Addictive; Central Nervous System Stimulants; Humans; Impulsive Behavior; Internet; Male; Methylphenidate; Psychiatric Status Rating Scales; Severity of Illness Index; Single-Blind Method; Treatment Outcome; Video Games	2016
Striatal Activation Predicts Differential Therapeutic Responses to Methylphenidate and Atomoxetine. Journal of the American Academy of Child and Adolescent Psychiatry, 2017, Volume: 56, Issue:7 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Caudate Nucleus; Central Nervous System Stimulants; Child; Female; Humans; Inhibition, Psychological; Magnetic Resonance Imaging; Male; Methylphenidate; Motor Cortex	2017
QTc prolongation after ADHD medication. Neuro endocrinology letters, 2018, Volume: 38, Issue:8 Topics: Adolescent; Adrenergic Uptake Inhibitors; Arrhythmias, Cardiac; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Male; Methylphenidate; Slovakia	2018
Efficacy of Hippotherapy Versus Pharmacotherapy in Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial. Journal of alternative and complementary medicine (New York, N.Y.), 2018, Volume: 24, Issue:5 Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child Behavior; Electroencephalography; Equine-Assisted Therapy; Female; Humans; Male; Methylphenidate	2018
Comparative Efficacy of Methylphenidate and Atomoxetine on Emotional and Behavioral Problems in Youths with Attention-Deficit/Hyperactivity Disorder. Journal of child and adolescent psychopharmacology, 2019, Volume: 29, Issue:1 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Emotions; Female; Humans; Male; Methylphenidate; Problem Behavior; Surveys and Questionnaires	2019
Catecholamine Modulation of Evidence Accumulation during Perceptual Decision Formation: A Randomized Trial. Journal of cognitive neuroscience, 2019, Volume: 31, Issue:7 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Brain; Catecholamines; Citalopram; Cross-Over Studies; Decision Making; Dopamine Uptake Inhibitors; Double-Blind Method; Electroencephalography; Evoked Potentials, Visual; Humans; Male; Methylphenidate; Middle Aged; Selective Serotonin Reuptake Inhibitors; Visual Perception; Young Adult	2019
Methylphenidate and atomoxetine normalise fronto-parietal underactivation during sustained attention in ADHD adolescents. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2019, Volume: 29, Issue:10 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention; Attention Deficit Disorder with Hyperactivity; Brain; Central Nervous System Stimulants; Child; Cross-Over Studies; Double-Blind Method; Functional Neuroimaging; Humans; Magnetic Resonance Imaging; Male; Methylphenidate; Neural Pathways; Neuropsychological Tests	2019
Pharmacological Manipulations of Physiological Arousal and Sleep-Like Slow Waves Modulate Sustained Attention. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2022, 10-26, Volume: 42, Issue:43 Topics: Atomoxetine Hydrochloride; Attention; Citalopram; Dopamine; Electroencephalography; Humans; Male; Methylphenidate; Norepinephrine; Serotonin; Sleep; Wakefulness	2022
Single-dose effects of methylphenidate and atomoxetine on functional connectivity during an n-back task in boys with ADHD. Psychopharmacology, 2023, Volume: 240, Issue:10 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain; Central Nervous System Stimulants; Child; Frontal Lobe; Humans; Magnetic Resonance Imaging; Male; Methylphenidate	2023

Other Studies

221 other study(ies) available for atomoxetine hydrochloride and methylphenidate

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Glutamatergic changes with treatment in attention deficit hyperactivity disorder: a preliminary case series. Journal of child and adolescent psychopharmacology, 2002,Winter, Volume: 12, Issue:4 Topics: Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Creatinine; Female; Glutamic Acid; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Methylphenidate; Neostriatum; Prefrontal Cortex; Propylamines; Psychiatric Status Rating Scales	2002
Updates on attention deficit hyperactivity disorder, child abuse and neglect, and sudden infant death syndrome. Current opinion in pediatrics, 2003, Volume: 15, Issue:2 Topics: Adrenergic Uptake Inhibitors; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child Abuse; Child Abuse, Sexual; Desipramine; Dopamine Uptake Inhibitors; Humans; Infant; Methylphenidate; Prone Position; Propylamines; Risk Factors; Sudden Infant Death	2003
Enhanced attention in rhesus monkeys as a common factor for the cognitive effects of drugs with abuse potential. Psychopharmacology, 2003, Volume: 169, Issue:2 Topics: Animals; Atomoxetine Hydrochloride; Attention; Caffeine; Cognition; Cognition Disorders; Color Perception; Female; Macaca mulatta; Macaca nemestrina; Male; Methylphenidate; Morphine; Neuropsychological Tests; Nicotine; Nomifensine; Photic Stimulation; Propylamines; Substance-Related Disorders; Task Performance and Analysis	2003
[New therapeutic options in the treatment of attention deficit/hyperactivity disorder]. Revista de neurologia, 2004, Volume: 38 Suppl 1 Topics: Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain; Central Nervous System Stimulants; Clinical Trials as Topic; Dopamine; Dopamine Uptake Inhibitors; Humans; Methylphenidate; Norepinephrine; Propylamines	2004
Evaluation of the reinforcing effects of atomoxetine in monkeys: comparison to methylphenidate and desipramine. Drug and alcohol dependence, 2004, Sep-06, Volume: 75, Issue:3 Topics: Animals; Atomoxetine Hydrochloride; Desipramine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Macaca mulatta; Male; Methylphenidate; Propylamines; Reaction Time; Reinforcement, Psychology; Self Administration	2004
Evaluation of the reinforcing effects of monoamine reuptake inhibitors under a concurrent schedule of food and i.v. drug delivery in rhesus monkeys. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2005, Volume: 30, Issue:4 Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain; Central Nervous System Stimulants; Cocaine; Desipramine; Dextroamphetamine; Disease Models, Animal; Dose-Response Relationship, Drug; Eating; Female; Infusion Pumps; Macaca mulatta; Methylphenidate; Propylamines; Reinforcement, Psychology; Self Administration; Substance-Related Disorders	2005
Review of new compounds available in Australia for the treatment of attention-deficit hyperactivity disorder. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 2004, Volume: 12, Issue:4 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Australia; Biological Availability; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Drug Administration Schedule; Drug Approval; Drug Costs; Drug Utilization; Humans; Inactivation, Metabolic; Metabolic Clearance Rate; Methylphenidate; Personality Assessment; Propylamines; Randomized Controlled Trials as Topic; Therapeutic Equivalency; Treatment Outcome	2004
The answerable question and a hierarchy of evidence. Journal of the American Academy of Child and Adolescent Psychiatry, 2005, Volume: 44, Issue:6 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Databases, Factual; Evidence-Based Medicine; Humans; Male; Methylphenidate; Personality Assessment; Propylamines; Quality Assurance, Health Care; Randomized Controlled Trials as Topic; Software; Treatment Outcome	2005
Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetine. Molecular psychiatry, 2006, Volume: 11, Issue:2 Topics: Acetylcholine; Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Central Nervous System Stimulants; Cerebral Cortex; Cholinergic Fibers; Hippocampus; Male; Maze Learning; Methylphenidate; Microdialysis; Morpholines; Norepinephrine; Pattern Recognition, Visual; Propylamines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reboxetine; Receptors, Dopamine	2006
Patients with attention-deficit/hyperactivity disorder without observed apneic episodes in sleep or daytime sleepiness have normal sleep on polysomnography. Sleep, 2005, Volume: 28, Issue:9 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cross-Over Studies; Disorders of Excessive Somnolence; Double-Blind Method; Female; Humans; Male; Methylphenidate; Nocturnal Myoclonus Syndrome; Polysomnography; Propylamines; Sleep; Sleep Apnea, Obstructive; Sleep Stages	2005
Discriminative-stimulus, self-reported, performance, and cardiovascular effects of atomoxetine in methylphenidate-trained humans. Experimental and clinical psychopharmacology, 2006, Volume: 14, Issue:2 Topics: Adolescent; Adult; Atomoxetine Hydrochloride; Blood Pressure; Discrimination Learning; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Male; Methylphenidate; Norepinephrine Plasma Membrane Transport Proteins; Propylamines	2006
Concomitant use of atomoxetine and OROS-methylphenidate in a 10-year-old child suffering from attention-deficit/hyperactivity disorder with comorbid bipolar disorder and Tourette syndrome. Journal of child and adolescent psychopharmacology, 2006, Volume: 16, Issue:3 Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous System Stimulants; Child; Clonidine; Comorbidity; Drug Therapy, Combination; Humans; Male; Methylphenidate; Propylamines; Tics; Tourette Syndrome	2006
Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain. Neuropharmacology, 2007, Volume: 52, Issue:2 Topics: Adrenergic Agents; Animals; Atomoxetine Hydrochloride; Brain; Dopamine; Dose-Response Relationship, Drug; Male; Methylphenidate; Microscopy, Electron, Transmission; Models, Biological; Norepinephrine; Propylamines; Rats; Rats, Sprague-Dawley; Synaptic Vesicles; Synaptosomes; Tritium	2007
Dimensional analysis of ADHD subtypes in rats. Biological psychiatry, 2007, Jun-15, Volume: 61, Issue:12 Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cluster Analysis; Disease Models, Animal; Disruptive, Impulse Control, and Conduct Disorders; Environment; Habituation, Psychophysiologic; Locomotion; Male; Methylphenidate; Photic Stimulation; Propylamines; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Time Factors; Treatment Outcome	2007
Pharmacological management of a youth with ADHD and a seizure disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 2006, Volume: 45, Issue:12 Topics: Adrenergic Uptake Inhibitors; Anticonvulsants; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Carbamazepine; Central Nervous System Stimulants; Child; Epilepsy; Humans; Male; Methylphenidate; Propylamines	2006
ADHD update: new data on the risks of medication. The Harvard mental health letter, 2006, Volume: 23, Issue:4 Topics: Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Death, Sudden, Cardiac; Drug Overdose; Growth Disorders; Humans; Methylphenidate; Propylamines	2006
Methylphenidate and atomoxetine increase histamine release in rat prefrontal cortex. European journal of pharmacology, 2007, Mar-08, Volume: 558, Issue:1-3 Topics: Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Histamine Release; Male; Methylphenidate; Prefrontal Cortex; Propylamines; Rats; Rats, Sprague-Dawley	2007
Combined overdose of atomoxetine and methylphenidate in a cytochrome P450 2D6 poor metabolizer. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:1 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Cytochrome P-450 CYP2D6; Drug Overdose; Female; Humans; Methylphenidate; Propylamines	2007
The neurobiology of attention-deficit/hyperactivity disorder. Biological psychiatry, 2007, Jun-15, Volume: 61, Issue:12 Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain; Central Nervous System Stimulants; Cerebellum; Child; Corpus Striatum; Disruptive, Impulse Control, and Conduct Disorders; Dopamine; Frontal Lobe; Humans; Methylphenidate; Nerve Net; Norepinephrine; Propylamines; Synaptic Transmission	2007
Seizure risk in patients with attention-deficit-hyperactivity disorder treated with atomoxetine. Developmental medicine and child neurology, 2007, Volume: 49, Issue:7 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Databases, Factual; Female; Humans; Male; Meta-Analysis as Topic; Methylphenidate; Product Surveillance, Postmarketing; Propylamines; Risk; Seizures	2007
Treatment of adult ADHD and comorbid disorders. CNS spectrums, 2006, Volume: 11, Issue:10 Suppl 1 Topics: Adult; Amphetamines; Antidepressive Agents, Tricyclic; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Clinical Trials as Topic; Humans; Methylphenidate; Propylamines; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2006
Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test. Progress in neuro-psychopharmacology & biological psychiatry, 2008, Jan-01, Volume: 32, Issue:1 Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention; Behavior, Animal; Central Nervous System Stimulants; Choice Behavior; Dose-Response Relationship, Drug; Impulsive Behavior; Male; Methylphenidate; Propylamines; Psychomotor Performance; Rats; Rats, Long-Evans; Reaction Time	2008
Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies. Journal of managed care pharmacy : JMCP, 2007, Volume: 13, Issue:7 Topics: Adrenergic Uptake Inhibitors; Adult; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Costs and Cost Analysis; Databases, Factual; Delayed-Action Preparations; Female; Health Care Costs; Humans; Insurance, Health; Insurance, Pharmaceutical Services; Male; Managed Care Programs; Methylphenidate; Middle Aged; Multivariate Analysis; Propylamines; Reproducibility of Results; Time Factors	2007
[Prescribing of stimulants for ADHD in Nordland County]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2007, Sep-20, Volume: 127, Issue:18 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Dextroamphetamine; Drug Prescriptions; Drug Utilization; Female; Humans; Male; Methylphenidate; Norway; Propylamines	2007
Sleep disturbances and ADHD medications. Current psychiatry reports, 2007, Volume: 9, Issue:5 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Humans; Methylphenidate; Polysomnography; Propylamines; Randomized Controlled Trials as Topic; Sleep Initiation and Maintenance Disorders	2007
Nicotine as a conditioned stimulus: impact of attention-deficit/hyperactivity disorder medications. Experimental and clinical psychopharmacology, 2007, Volume: 15, Issue:5 Topics: Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Bupropion; Cocaine; Conditioning, Operant; Conditioning, Psychological; Discrimination Learning; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Generalization, Psychological; Male; Methylphenidate; Nicotine; Nicotinic Antagonists; Piperazines; Propylamines; Rats; Rats, Sprague-Dawley	2007
Interactions of attention-deficit/hyperactivity disorder therapeutic agents with the efflux transporter P-glycoprotein. European journal of pharmacology, 2008, Jan-14, Volume: 578, Issue:2-3 Topics: Adenosine Triphosphate; Amphetamine; Animals; Atomoxetine Hydrochloride; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Biological Transport; Central Nervous System Stimulants; Cyclosporins; Dose-Response Relationship, Drug; Doxorubicin; Isomerism; LLC-PK1 Cells; Methylphenidate; Modafinil; Propylamines; Reproducibility of Results; Rhodamine 123; Swine; Transfection	2008
Is NICE infallible? A qualitative study of its assessment of treatments for attention-deficit/hyperactivity disorder (ADHD). Current medical research and opinion, 2008, Volume: 24, Issue:2 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Cost-Benefit Analysis; Dextroamphetamine; Evidence-Based Medicine; Humans; Methylphenidate; Models, Economic; Outcome and Process Assessment, Health Care; Propylamines; Qualitative Research; Technology Assessment, Biomedical; United Kingdom	2008
Methylphenidate disrupts social play behavior in adolescent rats. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2008, Volume: 33, Issue:12 Topics: Adrenergic Antagonists; Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Brain; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Exploratory Behavior; Male; Methylphenidate; Norepinephrine; Play and Playthings; Propylamines; Rats; Rats, Wistar; Social Behavior	2008
The Life Participation Scale for Attention-Deficit/Hyperactivity Disorder--Child Version: psychometric properties of an adaptive change instrument. Journal of child and adolescent psychopharmacology, 2007, Volume: 17, Issue:6 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Emotions; Factor Analysis, Statistical; Female; Humans; Male; Methylphenidate; Multicenter Studies as Topic; Parents; Propylamines; Psychiatric Status Rating Scales; Psychometrics; Quality of Life; Randomized Controlled Trials as Topic; Reproducibility of Results; Social Behavior	2007
Improving decision making in the treatment of ADHD. The American journal of psychiatry, 2008, Volume: 165, Issue:6 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cross-Over Studies; Decision Support Techniques; Humans; Methylphenidate; Practice Guidelines as Topic; Propylamines; Randomized Controlled Trials as Topic; Treatment Outcome	2008
Effects of atomoxetine and methylphenidate on performance of a lateralized reaction time task in rats. Psychopharmacology, 2009, Volume: 202, Issue:1-3 Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Central Nervous System Stimulants; Conditioning, Operant; Discrimination, Psychological; Functional Laterality; Male; Methylphenidate; Propylamines; Psychomotor Performance; Rats; Rats, Long-Evans; Reaction Time; Serial Learning	2009
Pharmacotherapy of ADHD in adults. CNS spectrums, 2008, Volume: 13, Issue:5 Suppl 8 Topics: Adrenergic Uptake Inhibitors; Adult; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Humans; Methylphenidate; Propylamines	2008
Inhibition of the norepinephrine transporter improves behavioral flexibility in rats and monkeys. Psychopharmacology, 2009, Volume: 202, Issue:1-3 Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Behavior, Animal; Chlorocebus aethiops; Choice Behavior; Desipramine; Discrimination, Psychological; Dopamine Uptake Inhibitors; Male; Memory; Methylphenidate; Norepinephrine Plasma Membrane Transport Proteins; Piperazines; Propylamines; Psychomotor Performance; Rats; Rats, Long-Evans; Reversal Learning; Space Perception	2009
[Comment on the European guidelines for use of delayed action drugs for treatment of hyperkinetic disorders]. Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie, 2008, Volume: 36, Issue:2 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Europe; Evidence-Based Medicine; Humans; Methylphenidate; Practice Guidelines as Topic; Propylamines; Psychotherapy; Treatment Outcome	2008
Atomoxetine-associated hemospermia: a case report. The Journal of clinical psychiatry, 2008, Volume: 69, Issue:7 Topics: Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Drug Administration Schedule; Hemospermia; Humans; Male; Methylphenidate; Propylamines	2008
Diagnosis and management of attention-deficit/hyperactivity disorder in children, young people, and adults: summary of NICE guidance. BMJ (Clinical research ed.), 2008, Sep-24, Volume: 337 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Counseling; Diet; Humans; Methylphenidate; Parents; Practice Guidelines as Topic; Propylamines; Teaching	2008
Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults. The British journal of psychiatry : the journal of mental science, 2009, Volume: 194, Issue:3 Topics: Adolescent; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Cohort Studies; Cross-Sectional Studies; Dextroamphetamine; Dopamine Uptake Inhibitors; Female; Humans; Male; Methylphenidate; Practice Patterns, Physicians'; Prevalence; Propylamines; United Kingdom; Withholding Treatment; Young Adult	2009
[Attention deficit hyperactivity disorder in adults]. Revista de neurologia, 2009, Feb-27, Volume: 48 Suppl 2 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cognitive Behavioral Therapy; Comorbidity; Female; Humans; Male; Memory Disorders; Methylphenidate; Propylamines; Social Behavior; Surveys and Questionnaires	2009
A modelled economic evaluation comparing atomoxetine with methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder in Spain. BMC psychiatry, 2009, Apr-14, Volume: 9 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Controlled Clinical Trials as Topic; Cost-Benefit Analysis; Humans; Markov Chains; Methylphenidate; Models, Economic; Propylamines; Spain	2009
[Without treatment the crash threatens]. MMW Fortschritte der Medizin, 2009, Jan-29, Volume: 151, Issue:5 Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Diagnosis, Differential; Early Diagnosis; Humans; Learning Disabilities; Methylphenidate; Prognosis; Propylamines	2009
Impact of drugs approved for treating ADHD on the cell survival and energy metabolism: an in-vitro study in human neuronal and immune cells. Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:12 Topics: Adenosine Triphosphate; Adrenergic Uptake Inhibitors; Amphetamine; Atomoxetine Hydrochloride; Cell Line, Tumor; Cell Survival; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Energy Metabolism; Humans; Methylphenidate; Monocytes; Neuroblastoma; Propylamines; U937 Cells	2010
Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD? Psychiatria Danubina, 2009, Volume: 21, Issue:3 Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Male; Methylphenidate; Propylamines; Treatment Outcome	2009
Mortality associated with attention-deficit hyperactivity disorder (ADHD) drug treatment: a retrospective cohort study of children, adolescents and young adults using the general practice research database. Drug safety, 2009, Volume: 32, Issue:11 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Cause of Death; Central Nervous System Stimulants; Child; Child, Preschool; Cohort Studies; Databases, Factual; Death, Sudden; Dextroamphetamine; Female; Humans; Male; Methylphenidate; Propylamines; Retrospective Studies; Risk Factors; Suicide; United Kingdom; Young Adult	2009
Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study. Health technology assessment (Winchester, England), 2009, Volume: 13, Issue:50 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Attitude to Health; Central Nervous System Stimulants; Continuity of Patient Care; Cross-Sectional Studies; Dextroamphetamine; Drug Utilization Review; Family Practice; Female; Humans; Male; Medication Adherence; Methylphenidate; Outcome and Process Assessment, Health Care; Pharmacoepidemiology; Practice Patterns, Physicians'; Propylamines; Quality of Life; Survival Analysis; United Kingdom; Withholding Treatment; Young Adult	2009
Attention-deficit hyperactivity disorder: recent advances in paediatric pharmacotherapy. Drugs, 2010, Volume: 70, Issue:1 Topics: Administration, Oral; Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Dexmethylphenidate Hydrochloride; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Approval; Drug Therapy, Combination; Half-Life; Health Care Costs; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Pediatrics; Prodrugs; Propylamines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Treatment Outcome	2010
Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples high-excitability rats. Behavioural brain research, 2010, Jun-26, Volume: 210, Issue:1 Topics: Adrenergic Uptake Inhibitors; Aging; Animals; Atomoxetine Hydrochloride; Attention; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Disease Models, Animal; Dopamine; Male; Maze Learning; Methylphenidate; Norepinephrine; Propylamines; Prosencephalon; Random Allocation; Rats; Serotonin; Time Factors	2010
Trends in incidence and characteristics of children, adolescents, and adults initiating immediate- or extended-release methylphenidate or atomoxetine in the Netherlands during 2001-2006. Journal of child and adolescent psychopharmacology, 2010, Volume: 20, Issue:1 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Age Factors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Drug Administration Schedule; Drug Prescriptions; Female; Humans; Incidence; Male; Methylphenidate; Netherlands; Propylamines; Sex Factors; Time Factors; Treatment Outcome	2010
A pilot study to evaluate a community pharmacy-based monitoring system to identify adverse drug reactions associated with paediatric medicines use. European journal of clinical pharmacology, 2010, Volume: 66, Issue:6 Topics: Adolescent; Adverse Drug Reaction Reporting Systems; Anticonvulsants; Atomoxetine Hydrochloride; Child; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Humans; Incidence; Infant; Infant, Newborn; Melatonin; Methylphenidate; Pharmacies; Pilot Projects; Propylamines; Prospective Studies; Sample Size; Scotland; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Surveys and Questionnaires	2010
The discrepancy in attention deficit hyperactivity disorder (ADHD) medications diffusion: 1994-2003--a global pharmaceutical data analysis. Health policy (Amsterdam, Netherlands), 2010, Volume: 97, Issue:1 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Central Nervous System Stimulants; Drug Costs; Drug Industry; Economics; Healthcare Disparities; Humans; Methylphenidate; Modafinil; Propylamines; Time Factors; United States	2010
Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice. Journal of neurochemistry, 2010, Volume: 114, Issue:1 Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Biogenic Monoamines; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Extracellular Space; Male; Methylphenidate; Mice; Mice, Inbred ICR; Microdialysis; Motor Activity; Neurons; Norepinephrine; Prefrontal Cortex; Propylamines; Proto-Oncogene Proteins c-fos; Serotonin	2010
Academy of Medicine Singapore-Ministry of Health clinical practice guidelines: Autism Spectrum Disorders in pre-school children. Singapore medical journal, 2010, Volume: 51, Issue:3 Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Benzodiazepines; Central Nervous System Stimulants; Child Development Disorders, Pervasive; Child, Preschool; Dopamine Antagonists; Humans; Mass Screening; Methylphenidate; Olanzapine; Prognosis; Propylamines; Risperidone; Selective Serotonin Reuptake Inhibitors; Singapore	2010
Atomoxetine. Attention-deficit/hyperactivity disorder: no better than methylphenidate. Prescrire international, 2010, Volume: 19, Issue:105 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Humans; Meta-Analysis as Topic; Methylphenidate; Propylamines; Randomized Controlled Trials as Topic	2010
Impact of psychostimulants and atomoxetine on the expression of 8-hydroxyguanine glycosylase 1 in human cells. Journal of neural transmission (Vienna, Austria : 1996), 2010, Volume: 117, Issue:6 Topics: Adrenergic Uptake Inhibitors; Amphetamine; Atomoxetine Hydrochloride; Cell Line; Central Nervous System Stimulants; DNA Glycosylases; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Humans; Methylphenidate; Monocytes; Neuroblastoma; Propylamines; RNA, Messenger	2010
Cardiovascular safety of ADHD medications: rationale for and design of an investigator-initiated observational study. Pharmacoepidemiology and drug safety, 2010, Volume: 19, Issue:9 Topics: Adolescent; Adrenergic Uptake Inhibitors; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Cardiovascular Diseases; Central Nervous System Stimulants; Child; Cohort Studies; Databases, Factual; Humans; Methylphenidate; Myocardial Infarction; Propylamines; Research Design; United States	2010
Newly approved once-daily formulations of medications for the treatment of Attention Deficit (Hyperactivity) Disorder (ADHD) in children and adolescents. Issues in mental health nursing, 2010, Volume: 31, Issue:8 Topics: Administration, Cutaneous; Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Dextroamphetamine; Drug Administration Schedule; Guanfacine; Humans; Lisdexamfetamine Dimesylate; Locus Coeruleus; Methylphenidate; Neurons; Nutrition Surveys; Prefrontal Cortex; Propylamines	2010
Sub-chronic exposure to atomoxetine up-regulates BDNF expression and signalling in the brain of adolescent spontaneously hypertensive rats: comparison with methylphenidate. Pharmacological research, 2010, Volume: 62, Issue:6 Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain; Brain-Derived Neurotrophic Factor; Central Nervous System Stimulants; Humans; Male; Methylphenidate; Propylamines; Rats; Rats, Inbred SHR; RNA, Messenger; Signal Transduction; Up-Regulation	2010
Methylphenidate and atomoxetine enhance prefrontal function through α2-adrenergic and dopamine D1 receptors. Journal of the American Academy of Child and Adolescent Psychiatry, 2010, Volume: 49, Issue:10 Topics: Adrenergic Uptake Inhibitors; Animals; Appetitive Behavior; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain Mapping; Central Nervous System Stimulants; Child; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Macaca mulatta; Male; Memory, Short-Term; Methylphenidate; Nerve Net; Orientation; Prefrontal Cortex; Propylamines; Pyramidal Cells; Receptors, Adrenergic, alpha-2; Receptors, Dopamine D1; Saccades	2010
Treatment stabilization in children and adolescents with attention-deficit/hyperactivity disorder: data from the Netherlands. Current medical research and opinion, 2010, Volume: 26, Issue:11 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cohort Studies; Female; Humans; Male; Medical Audit; Methylphenidate; Netherlands; Outcome Assessment, Health Care; Practice Patterns, Physicians'; Propylamines; Retrospective Studies	2010
Response requirement and increases in accuracy produced by stimulant drugs in a 5-choice serial reaction-time task in rats. Psychopharmacology, 2011, Volume: 213, Issue:4 Topics: Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Choice Behavior; Dextroamphetamine; Male; Methylphenidate; Nicotine; Nicotinic Agonists; Propylamines; Rats; Rats, Sprague-Dawley; Reaction Time; Reinforcement Schedule; Signal Detection, Psychological	2011
Sub-optimal performance in the 5-choice serial reaction time task in rats was sensitive to methylphenidate, atomoxetine and d-amphetamine, but unaffected by the COMT inhibitor tolcapone. Neuroscience research, 2011, Volume: 69, Issue:1 Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention; Benzophenones; Catechol O-Methyltransferase Inhibitors; Central Nervous System Stimulants; Choice Behavior; Dextroamphetamine; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Impulsive Behavior; Male; Methylphenidate; Nitrophenols; Norepinephrine; Prefrontal Cortex; Propylamines; Rats; Rats, Long-Evans; Reaction Time; Tolcapone	2011
Selective norepinephrine reuptake inhibition by atomoxetine prevents cue-induced heroin and cocaine seeking. Biological psychiatry, 2011, Feb-01, Volume: 69, Issue:3 Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Cocaine; Cues; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Heroin; Male; Methylphenidate; Propylamines; Rats; Reinforcement Schedule; Self Administration	2011
Effects of atomoxetine, desipramine, d-amphetamine and methylphenidate on impulsivity in juvenile rats, measured in a T-maze procedure. Neuroscience letters, 2011, Feb-01, Volume: 489, Issue:1 Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Central Nervous System Stimulants; Desipramine; Dextroamphetamine; Impulsive Behavior; Male; Methylphenidate; Propylamines; Rats; Rats, Wistar	2011
Less discontinuation of ADHD drug use since the availability of long-acting ADHD medication in children, adolescents and adults under the age of 45 years in the Netherlands. Attention deficit and hyperactivity disorders, 2010, Volume: 2, Issue:4 Topics: Adolescent; Adult; Age Factors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Community Pharmacy Services; Delayed-Action Preparations; Drug Utilization; Female; Humans; Infant; Male; Methylphenidate; Middle Aged; Netherlands; Propylamines; Sex Characteristics	2010
Combining carbamazepine, neuroleptics and acetylcholinesterase inhibitors with methylphenidate only reduces adverse side effects, but is less effective than a combination with atomoxetine. Medical hypotheses, 2011, Volume: 76, Issue:5 Topics: Aggression; Antipsychotic Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Carbamazepine; Child; Cholinesterase Inhibitors; Drug Synergism; Humans; Male; Methylphenidate; Propylamines; Time Factors; Treatment Outcome	2011
Transitioning to OROS(®) methylphenidate from atomoxetine is effective in children and adolescents with ADHD. Expert review of neurotherapeutics, 2011, Volume: 11, Issue:4 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Drug Administration Schedule; Female; Humans; Male; Methylphenidate; Propylamines; Prospective Studies; Psychiatric Status Rating Scales; Quality of Life; Treatment Outcome	2011
Pharmacologic treatment of attention-deficit/hyperactivity disorder in children: incidence, prevalence, and treatment patterns in the Netherlands. Clinical therapeutics, 2011, Volume: 33, Issue:2 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dextroamphetamine; Drug Therapy, Combination; Drug Utilization; Humans; Incidence; Medical Records; Methylphenidate; Netherlands; Patient Compliance; Prevalence; Propylamines; Retrospective Studies	2011
Modulation of high impulsivity and attentional performance in rats by selective direct and indirect dopaminergic and noradrenergic receptor agonists. Psychopharmacology, 2012, Volume: 219, Issue:2 Topics: Adrenergic Agonists; Animals; Animals, Outbred Strains; Atomoxetine Hydrochloride; Attention; Benzimidazoles; Choice Behavior; Dopamine Agonists; Guanfacine; Impulsive Behavior; Male; Methylphenidate; Piperazines; Propylamines; Quinpirole; Rats; Reaction Time; Serial Learning	2012
Blockade of noradrenaline re-uptake sites improves accuracy and impulse control in rats performing a five-choice serial reaction time tasks. Psychopharmacology, 2012, Volume: 219, Issue:2 Topics: Adrenergic Uptake Inhibitors; Animals; Animals, Outbred Strains; Atomoxetine Hydrochloride; Attention; Choice Behavior; Dose-Response Relationship, Drug; Impulsive Behavior; Male; Methylphenidate; Morpholines; Propylamines; Rats; Reaction Time; Reboxetine; Serial Learning; Time Factors	2012
ADHD medication use, adherence, persistence and cost among Texas Medicaid children. Current medical research and opinion, 2011, Volume: 27 Suppl 2 Topics: Adolescent; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Female; Humans; Male; Medicaid; Medication Adherence; Methylphenidate; Prodrugs; Propylamines; Regression Analysis; Retrospective Studies; Texas; United States	2011
Impulsive action and impulsive choice are mediated by distinct neuropharmacological substrates in rat. The international journal of neuropsychopharmacology, 2012, Volume: 15, Issue:10 Topics: Adrenergic Uptake Inhibitors; Aminopyridines; Animals; Atomoxetine Hydrochloride; Choice Behavior; Dopamine Uptake Inhibitors; Impulsive Behavior; Indoles; Ketanserin; Male; Methylphenidate; Propylamines; Rats; Rats, Long-Evans; Reaction Time; Serotonin 5-HT2 Receptor Antagonists	2012
The change of the cortisol levels in children with ADHD treated by methylphenidate or atomoxetine. Journal of psychiatric research, 2012, Volume: 46, Issue:3 Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Dopamine Uptake Inhibitors; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Methylphenidate; Pituitary-Adrenal System; Propylamines; Treatment Outcome	2012
Treatment practices in Tourette syndrome: the European perspective. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2012, Volume: 16, Issue:4 Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Depression; Europe; Fluoxetine; Fluvoxamine; Health Care Surveys; Humans; Methylphenidate; Obsessive-Compulsive Disorder; Physicians; Piperazines; Propylamines; Psychiatry; Quinolones; Risperidone; Sertraline; Sulpiride; Tourette Syndrome	2012
Validation of the AQT color-form additive model for screening and monitoring pharmacological treatment of ADHD. Journal of attention disorders, 2013, Volume: 17, Issue:3 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Association Learning; Atomoxetine Hydrochloride; Attention; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Color Perception; Female; Humans; Male; Mass Screening; Memory, Short-Term; Methylphenidate; Middle Aged; Neuropsychological Tests; Pattern Recognition, Visual; Propylamines; Psychometrics; Reaction Time; Reference Values; Reproducibility of Results; Retrospective Studies; Semantics; Treatment Outcome; Young Adult	2013
Differential effects of methylphenidate and atomoxetine on attentional processes in children with ADHD: an event-related potential study using the Attention Network Test. Progress in neuro-psychopharmacology & biological psychiatry, 2012, Apr-27, Volume: 37, Issue:1 Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention; Attention Deficit Disorder with Hyperactivity; Child; Cross-Over Studies; Dopamine Uptake Inhibitors; Evoked Potentials; Female; Humans; Male; Methylphenidate; Neuropsychological Tests; Photic Stimulation; Propylamines; Reaction Time	2012
The use of dopaminergic and stimulant drugs for the treatment of depression. Journal of psychosocial nursing and mental health services, 2012, Volume: 50, Issue:2 Topics: Amphetamines; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Brain; Central Nervous System Stimulants; Depressive Disorder, Major; Dextroamphetamine; Dopamine; Dopamine Agents; Drug Therapy, Combination; Epinephrine; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Modafinil; Norepinephrine; Propylamines	2012
Dissociable effects of methylphenidate, atomoxetine and placebo on regional cerebral blood flow in healthy volunteers at rest: a multi-class pattern recognition approach. NeuroImage, 2012, Apr-02, Volume: 60, Issue:2 Topics: Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Brain; Central Nervous System Stimulants; Cerebrovascular Circulation; Humans; Male; Methylphenidate; Pattern Recognition, Automated; Propylamines; Regional Blood Flow; Rest; Young Adult	2012
Altered cortical morphology in sensorimotor processing regions in adolescents and adults with attention-deficit/hyperactivity disorder. Brain research, 2012, Mar-22, Volume: 1445 Topics: Adolescent; Adult; Age Factors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain Mapping; Central Nervous System Stimulants; Cohort Studies; Cross-Sectional Studies; Female; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Methylphenidate; Middle Aged; Motor Cortex; Propylamines; Somatosensory Cortex; Surveys and Questionnaires; Young Adult	2012
[Atomoxetine in ADHD: caution]. La Revue du praticien, 2011, Volume: 61, Issue:9 Suppl Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; Cognition; Humans; Methylphenidate; Motor Activity; Propylamines; Randomized Controlled Trials as Topic; Seizures; Treatment Failure; Treatment Outcome	2011
[Update on Current Care guidelines: ADHD (attention-deficit/hyperactivity disorder, children and adolescents)]. Duodecim; laaketieteellinen aikakauskirja, 2012, Volume: 128, Issue:5 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delivery of Health Care, Integrated; Dextroamphetamine; Humans; Methylphenidate; Practice Guidelines as Topic; Propylamines	2012
The ADHD-susceptibility gene lphn3.1 modulates dopaminergic neuron formation and locomotor activity during zebrafish development. Molecular psychiatry, 2012, Volume: 17, Issue:9 Topics: Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Diencephalon; Disease Models, Animal; Dopamine Uptake Inhibitors; Dopaminergic Neurons; Gene Knockdown Techniques; Methylphenidate; Molecular Imaging; Motor Activity; Nerve Degeneration; Propylamines; Receptors, Peptide; Zebrafish	2012
Norepinephrine and dopamine modulate impulsivity on the five-choice serial reaction time task through opponent actions in the shell and core sub-regions of the nucleus accumbens. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2012, Volume: 37, Issue:9 Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Choice Behavior; Dopamine; Dopamine Uptake Inhibitors; Impulsive Behavior; Infusions, Intraventricular; Male; Methylphenidate; Motor Activity; Norepinephrine; Nucleus Accumbens; Propylamines; Psychomotor Performance; Reaction Time	2012
The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care. BMC pediatrics, 2012, Jun-19, Volume: 12 Topics: Adolescent; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Cohort Studies; Dextroamphetamine; Female; Humans; Incidence; Male; Methylphenidate; Middle Aged; Prevalence; Primary Health Care; Propylamines; Retrospective Studies; United Kingdom; Young Adult	2012
A population-based study of stimulant drug treatment of ADHD and academic progress in children. Pediatrics, 2012, Volume: 130, Issue:1 Topics: Achievement; Age Factors; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Educational Measurement; Female; Humans; Iceland; Language Arts; Male; Mathematics; Methylphenidate; Multivariate Analysis; Odds Ratio; Propylamines; Registries; Sex Factors; Treatment Outcome	2012
Effects of ADHD therapeutic agents, methylphenidate and atomoxetine, on hippocampal neurogenesis in the adolescent mouse dentate gyrus. Neuroscience letters, 2012, Aug-30, Volume: 524, Issue:2 Topics: Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain-Derived Neurotrophic Factor; Cell Differentiation; Cell Proliferation; Dentate Gyrus; Doublecortin Protein; Immunohistochemistry; Male; Methylphenidate; Mice; Mice, Inbred ICR; Neurogenesis; Neurons; Propylamines	2012
Age-specific prevalence, incidence of new diagnoses, and drug treatment of attention-deficit/hyperactivity disorder in Germany. Journal of child and adolescent psychopharmacology, 2012, Volume: 22, Issue:4 Topics: Adolescent; Adrenergic Uptake Inhibitors; Age Factors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Databases, Factual; Female; Germany; Humans; Incidence; International Classification of Diseases; Male; Methylphenidate; Prevalence; Propylamines; Sex Factors; Time Factors	2012
Is there a relationship between hyperactivity/inattention symptoms and poor oral health? Results from the GINIplus and LISAplus study. Clinical oral investigations, 2013, Volume: 17, Issue:5 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Cohort Studies; Dental Caries; Dental Enamel Hypoplasia; Dentition, Permanent; DMF Index; Female; Germany; Health Surveys; Humans; Logistic Models; Male; Methylphenidate; Oral Health; Oral Hygiene; Parents; Propylamines; Social Class; Surveys and Questionnaires; Tooth Injuries	2013
Physical exercise and catecholamine reuptake inhibitors affect orienting behavior and social interaction in a rat model of attention-deficit/hyperactivity disorder. Behavioral neuroscience, 2012, Volume: 126, Issue:6 Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Catecholamines; Disease Models, Animal; Dopamine Uptake Inhibitors; Female; Methylphenidate; Motor Activity; Physical Conditioning, Animal; Propylamines; Rats; Rats, Inbred SHR; Rats, Wistar; Social Behavior	2012
Persistence of pharmacological treatment into adulthood, in UK primary care, for ADHD patients who started treatment in childhood or adolescence. BMC psychiatry, 2012, Dec-05, Volume: 12 Topics: Adolescent; Adult; Age Factors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Female; Humans; Kaplan-Meier Estimate; Male; Methylphenidate; Patient Compliance; Propylamines; United Kingdom	2012
Safety of attention-deficit/hyperactivity disorder medications in children: an intensive pharmacosurveillance monitoring study. Journal of child and adolescent psychopharmacology, 2012, Volume: 22, Issue:6 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adverse Drug Reaction Reporting Systems; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Databases, Factual; Female; Humans; Italy; Male; Methylphenidate; Pharmacovigilance; Propylamines; Registries	2012
Cardiovascular measures in children and adolescents with attention-deficit/hyperactivity disorder who are new users of methylphenidate and atomoxetine. Journal of child and adolescent psychopharmacology, 2012, Volume: 22, Issue:6 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Cardiovascular Diseases; Central Nervous System Stimulants; Child; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Humans; Italy; Male; Methylphenidate; Propylamines; Prospective Studies; Registries	2012
Performance on a strategy set shifting task during adolescence in a genetic model of attention deficit/hyperactivity disorder: methylphenidate vs. atomoxetine treatments. Behavioural brain research, 2013, May-01, Volume: 244 Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Conditioning, Operant; Dopamine Uptake Inhibitors; Male; Methylphenidate; Propylamines; Rats; Reversal Learning; Species Specificity; Time Factors	2013
Four-year outcome in psychopharmacologically treated adults with attention-deficit/hyperactivity disorder: a questionnaire survey. The Journal of clinical psychiatry, 2013, Volume: 74, Issue:1 Topics: Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Delayed-Action Preparations; Dextroamphetamine; Female; Follow-Up Studies; Humans; Male; Medication Adherence; Methylphenidate; Norway; Prognosis; Propylamines; Surveys and Questionnaires; Treatment Outcome	2013
Management of adult attention deficit hyperactivity disorder in UK primary care: a survey of general practitioners. Health and quality of life outcomes, 2013, Feb-22, Volume: 11 Topics: Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Data Collection; Dextroamphetamine; General Practitioners; Humans; Male; Medication Adherence; Methylphenidate; Practice Patterns, Physicians'; Primary Health Care; Propylamines; Surveys and Questionnaires; Treatment Outcome; United Kingdom	2013
Methylphenidate and atomoxetine for treatment of nocturnal enuresis in a child with attention-deficit hyperactivity disorder. European child & adolescent psychiatry, 2013, Volume: 22, Issue:10 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Female; Humans; Methylphenidate; Nocturnal Enuresis; Propylamines; Treatment Outcome	2013
Daily methylphenidate and atomoxetine treatment impacts on clock gene protein expression in the mouse brain. Brain research, 2013, Jun-04, Volume: 1513 Topics: Analysis of Variance; Animals; Atomoxetine Hydrochloride; Brain; Central Nervous System Stimulants; Circadian Rhythm; CLOCK Proteins; Gene Expression Regulation; Male; Methylphenidate; Mice; Mice, Inbred C57BL; Neuroimaging; Propylamines; Proto-Oncogene Proteins c-fos	2013
A novel translational assay of response inhibition and impulsivity: effects of prefrontal cortex lesions, drugs used in ADHD, and serotonin 2C receptor antagonism. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2013, Volume: 38, Issue:11 Topics: Aminopyridines; Animals; Atomoxetine Hydrochloride; Disease Models, Animal; Impulsive Behavior; Indoles; Inhibition, Psychological; Male; Methylphenidate; Mice; Prefrontal Cortex; Propylamines; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Antagonists	2013
[ADHD register: post-marketing evaluation of the benefit-risk profile of drugs and promotion of the appropriateness]. Recenti progressi in medicina, 2013, Volume: 104, Issue:6 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Dopamine Uptake Inhibitors; Drug Industry; Female; Humans; Male; Methylphenidate; Product Surveillance, Postmarketing; Propylamines; Registries; Risk Assessment	2013
Effects of stimulants and atomoxetine on cortisol levels in children with ADHD. Psychiatry research, 2013, Oct-30, Volume: 209, Issue:3 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Female; Humans; Hydrocortisone; Male; Methylphenidate; Propylamines; Psychiatric Status Rating Scales; Saliva; Treatment Outcome	2013
Adverse drug reaction labelling for atomoxetine, methylphenidate and modafinil: comparison of product information for oral formulations in Australia, Denmark and the United States. Current drug safety, 2013, Volume: 8, Issue:3 Topics: Administration, Oral; Adverse Drug Reaction Reporting Systems; Atomoxetine Hydrochloride; Australia; Benzhydryl Compounds; Central Nervous System Stimulants; Denmark; Drug Industry; Drug Labeling; Humans; Methylphenidate; Modafinil; Propylamines; United States	2013
Five-fold increase in national prevalence rates of attention-deficit/hyperactivity disorder medications for children and adolescents with autism spectrum disorder, attention-deficit/hyperactivity disorder, and other psychiatric disorders: a Danish registe Journal of child and adolescent psychopharmacology, 2013, Volume: 23, Issue:7 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Denmark; Dextroamphetamine; Female; Humans; Male; Mental Disorders; Methylphenidate; Practice Patterns, Physicians'; Prevalence; Propylamines; Registries	2013
Attention-deficit/hyperactivity disorder drugs and growth: an Italian prospective observational study. Journal of child and adolescent psychopharmacology, 2013, Volume: 23, Issue:7 Topics: Adolescent; Adolescent Development; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Body Height; Body Weight; Central Nervous System Stimulants; Child; Child Development; Female; Humans; Italy; Male; Methylphenidate; Propylamines; Prospective Studies; Registries	2013
Toward systems neuroscience of shared and distinct neural effects of medications used to treat attention-deficit/hyperactivity disorder. Biological psychiatry, 2013, Oct-15, Volume: 74, Issue:8 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain; Humans; Male; Methylphenidate; Propylamines	2013
Methylphenidate and atomoxetine enhance sensory-evoked neuronal activity in the visual thalamus of male rats. Experimental and clinical psychopharmacology, 2013, Volume: 21, Issue:5 Topics: Action Potentials; Animals; Atomoxetine Hydrochloride; Dopamine Uptake Inhibitors; Geniculate Bodies; Male; Methylphenidate; Neurons; Photic Stimulation; Propylamines; Rats; Sensory Gating	2013
Animal model of methylphenidate's long-term memory-enhancing effects. Learning & memory (Cold Spring Harbor, N.Y.), 2014, Jan-16, Volume: 21, Issue:2 Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Atomoxetine Hydrochloride; Bupropion; Central Nervous System Stimulants; Citalopram; Cocaine; Conditioning, Classical; Dose-Response Relationship, Drug; Fear; Female; Locomotion; Male; Maze Learning; Memory, Long-Term; Methylphenidate; Mice; Mice, Inbred C57BL; Nootropic Agents; Propylamines; Reinforcement, Psychology; Selective Serotonin Reuptake Inhibitors; Space Perception	2014
Atomoxetine reduces anticipatory responding in a 5-choice serial reaction time task for adult zebrafish. Psychopharmacology, 2014, Volume: 231, Issue:13 Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Choice Behavior; Disease Models, Animal; Female; Impulsive Behavior; Male; Methylphenidate; Propylamines; Reaction Time; Zebrafish	2014
ADHD Medication Trends in Turkey: 2009-2013. Journal of attention disorders, 2017, Volume: 21, Issue:14 Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Databases, Factual; Delayed-Action Preparations; Drug Administration Schedule; Drug Prescriptions; Female; Humans; Male; Methylphenidate; Practice Patterns, Physicians'; Seasons; Treatment Outcome; Turkey	2017
[Drug therapy for AD/HD investigation of usefulness of extended-release methylphenidate and atomoxetine from the viewpoint of persistency rate]. No to hattatsu = Brain and development, 2014, Volume: 46, Issue:1 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Child Development Disorders, Pervasive; Drug Therapy, Combination; Female; Humans; Male; Methylphenidate; Propylamines; Treatment Outcome; Young Adult	2014
Prefrontal grey and white matter neurometabolite changes after atomoxetine and methylphenidate in children with attention deficit/hyperactivity disorder: a (1)H magnetic resonance spectroscopy study. Psychiatry research, 2014, Apr-30, Volume: 222, Issue:1-2 Topics: Adolescent; Adrenergic Uptake Inhibitors; Aspartic Acid; Atomoxetine Hydrochloride; Attention; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Choline; Creatine; Female; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Male; Methylphenidate; Nerve Fibers, Myelinated; Nerve Fibers, Unmyelinated; Prefrontal Cortex; Propylamines; Treatment Outcome	2014
A nationwide study of attention-deficit/hyperactivity disorder drug use among adults in Iceland 2003-2012. Basic & clinical pharmacology & toxicology, 2014, Volume: 115, Issue:5 Topics: Adult; Age Factors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Female; Humans; Iceland; Male; Methylphenidate; Middle Aged; Practice Patterns, Physicians'; Prevalence; Propylamines; Time Factors; Young Adult	2014
Predictors of pharmacological treatment outcomes with atomoxetine or methylphenidate in patients with attention-deficit/hyperactivity disorder from China, Egypt, Lebanon, Russian Federation, Taiwan, and United Arab Emirates. International journal of clinical practice, 2014, Volume: 68, Issue:9 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; China; Egypt; Female; Humans; Lebanon; Male; Methylphenidate; Propylamines; Prospective Studies; Russia; Taiwan; Treatment Outcome; United Arab Emirates	2014
Cocaine-seeking behavior in a genetic model of attention-deficit/hyperactivity disorder following adolescent methylphenidate or atomoxetine treatments. Drug and alcohol dependence, 2014, Jul-01, Volume: 140 Topics: Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cocaine-Related Disorders; Conditioning, Operant; Drug-Seeking Behavior; Extinction, Psychological; Male; Methylphenidate; Propylamines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar; Species Specificity	2014
Genetic and pharmacological modulation of the steroid sulfatase axis improves response control; comparison with drugs used in ADHD. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2014, Volume: 39, Issue:11 Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Agents; Central Nervous System Stimulants; Coumarins; Dehydroepiandrosterone Sulfate; Disease Models, Animal; Enzyme Inhibitors; Inhibition, Psychological; Male; Methylphenidate; Mice, Transgenic; Neuropsychological Tests; Propylamines; Psychomotor Performance; Steryl-Sulfatase; Sulfonamides	2014
Pay attention to impulsivity: modelling low attentive and high impulsive subtypes of adult ADHD in the 5-choice continuous performance task (5C-CPT) in female rats. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2014, Volume: 24, Issue:8 Topics: Analysis of Variance; Animals; Atomoxetine Hydrochloride; Attention; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Choice Behavior; Disease Models, Animal; Female; Impulsive Behavior; Methylphenidate; Propylamines; Rats; Reaction Time	2014
Role of medial prefrontal and orbitofrontal monoamine transporters and receptors in performance in an adjusting delay discounting procedure. Brain research, 2014, Jul-29, Volume: 1574 Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Atomoxetine Hydrochloride; Behavior, Addictive; Central Nervous System Stimulants; Choice Behavior; Delay Discounting; Dopamine Agents; Dose-Response Relationship, Drug; Impulsive Behavior; Male; Methylphenidate; Prefrontal Cortex; Propylamines; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Serotonin Agents; Vesicular Monoamine Transport Proteins	2014
Using the five-choice serial reaction time task to examine the effects of atomoxetine and methylphenidate in the male spontaneously hypertensive rat. Pharmacology, biochemistry, and behavior, 2014, Volume: 124 Topics: Animals; Atomoxetine Hydrochloride; Central Nervous System Stimulants; Male; Methylphenidate; Propylamines; Rats; Rats, Inbred SHR; Reaction Time	2014
Drug treatment for attention-deficit/hyperactivity disorder and suicidal behaviour: register based study. BMJ (Clinical research ed.), 2014, Jun-18, Volume: 348 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Female; Humans; Incidence; Longitudinal Studies; Male; Methylphenidate; Middle Aged; Propylamines; Registries; Suicide; Sweden; Young Adult	2014
The effects of atomoxetine and methylphenidate on the prepulse inhibition of the acoustic startle response in mice. Progress in neuro-psychopharmacology & biological psychiatry, 2014, Oct-03, Volume: 54 Topics: Acoustic Stimulation; Adrenergic Uptake Inhibitors; Animals; Apomorphine; Atomoxetine Hydrochloride; Auditory Perception; Dizocilpine Maleate; Dopamine Agonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Male; Methylphenidate; Mice, Inbred ICR; Nucleus Accumbens; Prepulse Inhibition; Propylamines; Proto-Oncogene Proteins c-fos; Reflex, Startle; Sensory Gating	2014
Medical treatment of children and youths with attention-deficit/hyperactivity disorder (ADHD): a Norwegian Prescription Registry Based Study. Global journal of health science, 2014, Apr-14, Volume: 6, Issue:4 Topics: Adolescent; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Dextroamphetamine; Drug Utilization; Female; Humans; Male; Methylphenidate; Norway; Practice Patterns, Physicians'; Propylamines; Quality of Life; Registries; Residence Characteristics	2014
Comparison of pregnancy and lactation labeling for attention-deficit hyperactivity disorder drugs marketed in Australia, the USA, Denmark, and the UK. Drug safety, 2014, Volume: 37, Issue:10 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Australia; Benzhydryl Compounds; Central Nervous System Stimulants; Contraindications; Data Collection; Denmark; Drug Labeling; Female; Humans; Lactation; Methylphenidate; Modafinil; Pregnancy; Propylamines; United Kingdom; United States	2014
Early discontinuation of attention-deficit/hyperactivity disorder drug treatment: a Danish nationwide drug utilization study. Basic & clinical pharmacology & toxicology, 2015, Volume: 116, Issue:4 Topics: Adolescent; Adult; Age Factors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Chemistry, Pharmaceutical; Child; Denmark; Drug Prescriptions; Drug Utilization; Female; Health Care Surveys; Humans; Male; Methylphenidate; Middle Aged; Sex Factors; Young Adult	2015
[Pharmacological management of attention deficit hyperactivity disorder with methylphenidate and atomoxetine within a context of epilepsy]. Revista de neurologia, 2014, Feb-24, Volume: 58 Suppl 1 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Disease Management; Electroencephalography; Epilepsy; Female; Follow-Up Studies; Humans; Male; Methylphenidate; Retrospective Studies	2014
Impact of a restrictive drug access program on the risk of cardiovascular encounters in children exposed to ADHD medications. Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique, 2014, Volume: 21, Issue:3 Topics: Adolescent; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Cardiovascular Diseases; Case-Control Studies; Central Nervous System Stimulants; Child; Drug Costs; Emergency Service, Hospital; Female; Health Services Accessibility; Hospitalization; Humans; Insurance, Health, Reimbursement; Insurance, Pharmaceutical Services; Logistic Models; Male; Methylphenidate; Odds Ratio; Office Visits; Program Evaluation; Propylamines; Quebec; Risk Assessment; Risk Factors	2014
Treatment receipt and outcomes from a clinic employing the attention-deficit/hyperactivity disorder treatment guideline of the children's medication algorithm project. Journal of child and adolescent psychopharmacology, 2014, Volume: 24, Issue:9 Topics: Adolescent; Algorithms; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Female; Humans; Male; Medication Adherence; Methylphenidate; Practice Guidelines as Topic; Propylamines; Treatment Outcome	2014
Treatment compliance or medication adherence in children and adolescents on ADHD medication in clinical practice: results from the COMPLY observational study. Attention deficit and hyperactivity disorders, 2015, Volume: 7, Issue:2 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Female; Humans; Male; Medication Adherence; Methylphenidate; Prospective Studies; Time Factors	2015
Effectiveness of one-year pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD): an open-label prospective study of time in treatment, dose, side-effects and comorbidity. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2014, Volume: 24, Issue:12 Topics: Adrenergic Uptake Inhibitors; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Medication Adherence; Mental Disorders; Methylphenidate; Propylamines; Prospective Studies; Psychiatric Status Rating Scales; Stress, Psychological; Time Factors; Young Adult	2014
Methylphenidate and atomoxetine inhibit social play behavior through prefrontal and subcortical limbic mechanisms in rats. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015, Jan-07, Volume: 35, Issue:1 Topics: Animals; Atomoxetine Hydrochloride; Central Nervous System Stimulants; Exploratory Behavior; Injections, Intraventricular; Interpersonal Relations; Limbic System; Male; Methylphenidate; Play and Playthings; Prefrontal Cortex; Propylamines; Rats	2015
Psychostimulants and atomoxetine alter the electrophysiological activity of prefrontal cortex neurons, interaction with catecholamine and glutamate NMDA receptors. Psychopharmacology, 2015, Volume: 232, Issue:12 Topics: Animals; Atomoxetine Hydrochloride; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Electrophysiological Phenomena; Male; Methylphenidate; Neurons; Prefrontal Cortex; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Catecholamine; Receptors, Dopamine D1; Receptors, N-Methyl-D-Aspartate	2015
Injury prevention by medication among children with attention-deficit/hyperactivity disorder: a case-only study. JAMA pediatrics, 2015, Volume: 169, Issue:4 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain Injuries; Central Nervous System Stimulants; Child; Child, Preschool; Germany; Hospitalization; Humans; Incidence; Methylphenidate; Propylamines; Risk; Wounds and Injuries	2015
[Reconsider the diagnosis and treatment approach for ADHD]. Lakartidningen, 2015, Feb-24, Volume: 112 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Female; Humans; Male; Methylphenidate; Sex Factors	2015
Differences in abuse potential of ADHD drugs measured by contrasting poison centre and therapeutic use data. Clinical toxicology (Philadelphia, Pa.), 2015, Volume: 53, Issue:4 Topics: Adolescent; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Denmark; Drug Utilization; Female; Humans; Male; Methylphenidate; Poison Control Centers; Propylamines; Registries; Retrospective Studies; Substance-Related Disorders; Young Adult	2015
Trends in attention-deficit/hyperactivity disorder drug consumption in children and adolescents in Slovenia from 2001 to 2012: a drug use study from a national perspective. Journal of child and adolescent psychopharmacology, 2015, Volume: 25, Issue:3 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Databases, Factual; Drug Approval; Drug Costs; Drug Delivery Systems; Humans; Methylphenidate; Practice Patterns, Physicians'; Slovenia	2015
Assessment and treatment of attention-deficit/hyperactivity disorder: part 2. Pediatric annals, 2015, Volume: 44, Issue:4 Topics: Adolescent; Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; Child; Child, Preschool; Humans; Methylphenidate	2015
[Children's relative age in class and medication for attention-deficit/hyperactivity disorder. A population-based study in a health department in Spain]. Medicina clinica, 2015, Dec-07, Volume: 145, Issue:11 Topics: Age Factors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cross-Sectional Studies; Drug Therapy, Combination; Female; Humans; Male; Methylphenidate; Prevalence; Seasons; Spain; Students	2015
Dextroamphetamine (but Not Atomoxetine) Induces Reanimation from General Anesthesia: Implications for the Roles of Dopamine and Norepinephrine in Active Emergence. PloS one, 2015, Volume: 10, Issue:7 Topics: Anesthesia, General; Animals; Arousal; Atomoxetine Hydrochloride; Benzazepines; Consciousness; Dextroamphetamine; Dopamine; Electroencephalography; Male; Methyl Ethers; Methylphenidate; Norepinephrine; Propofol; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Sevoflurane	2015
Contrasting Roles of Dopamine and Noradrenaline in the Motivational Properties of Social Play Behavior in Rats. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2016, Volume: 41, Issue:3 Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Cocaine; Conditioning, Operant; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Flupenthixol; Idazoxan; Male; Methylphenidate; Motivation; Neuropsychological Tests; Norepinephrine; Piperazines; Random Allocation; Rats, Wistar; Receptors, Adrenergic, alpha-2; Receptors, Dopamine; Social Behavior	2016
Combined methylphenidate and atomoxetine pharmacotherapy in attention deficit hyperactivity disorder. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2015, Volume: 16, Issue:8 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Diagnostic and Statistical Manual of Mental Disorders; Drug Therapy, Combination; Female; Headache; Humans; Male; Methylphenidate; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome	2015
Effect of drugs on the risk of injuries in children with attention deficit hyperactivity disorder: a prospective cohort study. The lancet. Psychiatry, 2015, Volume: 2, Issue:8 Topics: Accidents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Cohort Studies; Denmark; Dextroamphetamine; Female; Humans; Male; Methylphenidate; Prospective Studies; Wounds and Injuries	2015
Quantification of Methylphenidate, Dexamphetamine, and Atomoxetine in Human Serum and Oral Fluid by HPLC With Fluorescence Detection. Therapeutic drug monitoring, 2016, Volume: 38, Issue:1 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Central Nervous System Stimulants; Child; Chromatography, High Pressure Liquid; Dextroamphetamine; Drug Monitoring; Female; Humans; Liquid-Liquid Extraction; Male; Methylphenidate; Middle Aged; Spectrometry, Fluorescence; Young Adult	2016
Differential therapeutic effects of 12-week treatment of atomoxetine and methylphenidate on drug-naïve children with attention deficit/hyperactivity disorder: A counting Stroop functional MRI study. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2015, Volume: 25, Issue:12 Topics: Adolescent; Adrenergic Uptake Inhibitors; Analysis of Variance; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain; Central Nervous System Stimulants; Child; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Methylphenidate; Neuropsychological Tests; Oxygen; Psychiatric Status Rating Scales; Taiwan	2015
Attention-deficit hyperactivity disorder, its treatment with medication and the probability of developing a depressive disorder: A nationwide population-based study in Taiwan. Journal of affective disorders, 2016, Jan-01, Volume: 189 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Comorbidity; Depressive Disorder; Female; Humans; Male; Methylphenidate; Probability; Retrospective Studies; Taiwan	2016
Attention-deficit hyperactivity disorder, its pharmacotherapy, and the risk of developing bipolar disorder: A nationwide population-based study in Taiwan. Journal of psychiatric research, 2016, Volume: 72 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous System Stimulants; Child; Cohort Studies; Comorbidity; Female; Follow-Up Studies; Humans; Male; Methylphenidate; Risk; Survival Analysis; Taiwan	2016
Impact of negative media publicity on attention-deficit/hyperactivity disorder medication in Taiwan. Pharmacoepidemiology and drug safety, 2016, Volume: 25, Issue:1 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Databases, Factual; Female; Humans; Inappropriate Prescribing; Insurance, Pharmaceutical Services; Male; Medical Overuse; Methylphenidate; Social Media; Taiwan	2016
Effects of methylphenidate and atomoxetine on impulsivity and motor activity in preadolescent rats prenatally-treated with alcohol. Behavioral neuroscience, 2015, Volume: 129, Issue:6 Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Central Nervous System Depressants; Central Nervous System Stimulants; Delay Discounting; Disease Models, Animal; Ethanol; Female; Fetal Alcohol Spectrum Disorders; Impulsive Behavior; Male; Methylphenidate; Motor Activity; Pregnancy; Prenatal Exposure Delayed Effects; Psychotropic Drugs; Rats, Wistar	2015
Exploratory analysis of early treatment discontinuation and clinical outcomes of patients with attention-deficit/hyperactivity disorder. Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists, 2017, Volume: 9, Issue:1 Topics: Adolescent; Atomoxetine Hydrochloride; Attention; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; China; Female; Humans; Male; Medication Adherence; Methylphenidate; Treatment Outcome	2017
Improvement by methylphenidate and atomoxetine of social interaction deficits and recognition memory impairment in a mouse model of valproic acid-induced autism. Autism research : official journal of the International Society for Autism Research, 2016, Volume: 9, Issue:9 Topics: Animals; Atomoxetine Hydrochloride; Autistic Disorder; Behavior, Animal; Dendritic Spines; Disease Models, Animal; Dopamine; Female; Humans; Interpersonal Relations; Male; Methylphenidate; Mice; Mice, Inbred ICR; Norepinephrine; Prefrontal Cortex; Pregnancy; Receptors, Dopamine D1; Recognition, Psychology; Valproic Acid	2016
Age-related changes in prefrontal norepinephrine transporter density: The basis for improved cognitive flexibility after low doses of atomoxetine in adolescent rats. Brain research, 2016, Jun-15, Volume: 1641, Issue:Pt B Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention; Central Nervous System Stimulants; Cognition; Dopamine beta-Hydroxylase; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Executive Function; Male; Methylphenidate; Nootropic Agents; Norepinephrine Plasma Membrane Transport Proteins; Piperazines; Prefrontal Cortex; Random Allocation; Rats	2016
Risk of Injury According to Attention Deficit Hyperactivity Disorder, Comorbid Mental Illness, and Medication Therapy. Pharmacopsychiatry, 2016, Volume: 49, Issue:2 Topics: Adolescent; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Comorbidity; Female; Humans; Infant; Male; Methylphenidate; Middle Aged; Neurotic Disorders; Personality Disorders; Psychoses, Substance-Induced; Psychotic Disorders; United States; Wounds and Injuries; Young Adult	2016
Seasonal Patterns of Medications for Treating Attention-Deficit/Hyperactivity Disorder: Comparison of Methylphenidate and Atomoxetine. Clinical therapeutics, 2016, Volume: 38, Issue:3 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Chemistry, Pharmaceutical; Child; Child, Preschool; Databases, Factual; Female; Humans; Male; Methylphenidate; Seasons; Taiwan	2016
Switch in Therapy from Methylphenidate to Atomoxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: An Analysis of Patient Records. Journal of child and adolescent psychopharmacology, 2016, Volume: 26, Issue:4 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Denmark; Drug Substitution; Electronic Health Records; Female; Humans; Male; Medication Adherence; Methylphenidate; Patient Preference; Time Factors; Treatment Outcome	2016
The impact of a model-based clinical regional registry for attention-deficit hyperactivity disorder. Health informatics journal, 2017, Volume: 23, Issue:3 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Electronic Health Records; Female; Health Information Exchange; Humans; Italy; Male; Medical Informatics; Methylphenidate; Psychotropic Drugs; Registries	2017
Factors predicting treatment adherence in patients with adult attention-deficit/hyperactivity disorder: a preliminary study. Attention deficit and hyperactivity disorders, 2016, Volume: 8, Issue:3 Topics: Adolescent; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Female; Humans; Male; Medication Adherence; Methylphenidate; Middle Aged; Risk Factors; Young Adult	2016
Prevalence rates of youths diagnosed with and medicated for ADHD in a nationwide survey in Taiwan from 2000 to 2011. Epidemiology and psychiatric sciences, 2017, Volume: 26, Issue:6 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cohort Studies; Female; Humans; Male; Medical Overuse; Methylphenidate; Population Surveillance; Prevalence; Taiwan	2017
Differences in Utilization Patterns among Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: a 36-Month Retrospective Study Using the Korean Health Insurance Review and Assessment Claims Database. Journal of Korean medical science, 2016, Volume: 31, Issue:8 Topics: Administration, Oral; Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Databases, Factual; Drug Compounding; Female; Humans; Insurance Claim Review; Logistic Models; Male; Medication Adherence; Methylphenidate; Odds Ratio; Republic of Korea; Retrospective Studies	2016
Development of a refill pattern method to measure polypharmacy in administrative claims databases. Pharmacoepidemiology and drug safety, 2016, Volume: 25, Issue:12 Topics: Adolescent; Algorithms; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Databases, Factual; Dexmethylphenidate Hydrochloride; Female; Humans; Male; Methylphenidate; Pharmacoepidemiology; Polypharmacy; Time Factors	2016
A Cost-Utility Analysis of Lisdexamfetamine Versus Atomoxetine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Inadequate Response to Methylphenidate. CNS drugs, 2016, Volume: 30, Issue:10 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cost-Benefit Analysis; Female; Health Resources; Humans; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Probability; Quality-Adjusted Life Years; Treatment Outcome	2016
Differential effects of methylphenidate and atomoxetine on intrinsic brain activity in children with attention deficit hyperactivity disorder. Psychological medicine, 2016, Volume: 46, Issue:15 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain; Child; Dopamine Uptake Inhibitors; Female; Frontal Lobe; Functional Neuroimaging; Humans; Magnetic Resonance Imaging; Male; Methylphenidate; Occipital Lobe; Parietal Lobe; Somatosensory Cortex; Treatment Outcome	2016
Use of drugs for ADHD among adults-a multinational study among 15.8 million adults in the Nordic countries. European journal of clinical pharmacology, 2016, Volume: 72, Issue:12 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Databases, Factual; Dextroamphetamine; Drug Utilization; Female; Humans; Male; Methylphenidate; Middle Aged; Psychotropic Drugs; Scandinavian and Nordic Countries; Young Adult	2016
Prevalence of medically treated children with ADHD and type 1 diabetes in Germany - Analysis of two representative databases. Journal of pediatric endocrinology & metabolism : JPEM, 2016, Nov-01, Volume: 29, Issue:11 Topics: Adolescent; Age Factors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Cohort Studies; Comorbidity; Dextroamphetamine; Diabetes Mellitus, Type 1; Drug Prescriptions; Female; Germany; Humans; Hypoglycemic Agents; Insulin; Male; Methylphenidate; Neurotransmitter Uptake Inhibitors; Prevalence; Prospective Studies; Risk Factors; Sex Factors	2016
Comparative treatment patterns, healthcare resource utilization and costs of atomoxetine and long-acting methylphenidate among children and adolescents with attention-deficit/hyperactivity disorder in Germany. The European journal of health economics : HEPAC : health economics in prevention and care, 2017, Volume: 18, Issue:7 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Female; Germany; Health Resources; Humans; Male; Methylphenidate; Models, Econometric; Retrospective Studies	2017
Long term pharmacotherapy by methylfenidate or atomoxetine DAT 1 10/10 ADHD children in correlation with results of the imaging methods. Neuro endocrinology letters, 2016, Volume: 37, Issue:4 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain; Central Nervous System Stimulants; Dopamine Plasma Membrane Transport Proteins; Female; Gray Matter; Humans; Magnetic Resonance Imaging; Male; Methylphenidate; Occipital Lobe; Organ Size; Polymorphism, Genetic; Prefrontal Cortex; Prognosis	2016
Prescribing patterns for attention deficit hyperactivity disorder medications among children and adolescents in Korea, 2007-2011. Epidemiology and health, 2016, Volume: 38 Topics: Adolescent; Age Distribution; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Drug Prescriptions; Female; Humans; Infant; Insurance Claim Review; Male; Methylphenidate; Practice Patterns, Physicians'; Prevalence; Republic of Korea	2016
Sensitivity of Quantitative Signal Detection in Regards to Pharmacological Neuroenhancement. International journal of molecular sciences, 2017, Jan-05, Volume: 18, Issue:1 Topics: Adrenergic Uptake Inhibitors; Adverse Drug Reaction Reporting Systems; Atomoxetine Hydrochloride; Australia; Benzhydryl Compounds; Canada; Central Nervous System Stimulants; Drug-Related Side Effects and Adverse Reactions; Excitatory Amino Acid Antagonists; France; Germany; Humans; Italy; Memantine; Methylphenidate; Modafinil; Pharmacovigilance; Spain; Substance-Related Disorders; United Kingdom; United States; Wakefulness-Promoting Agents	2017
Age-related pharmacotherapy of attention deficit hyperactivity disorder in Slovenia in children and adolescents: A population-based study. European psychiatry : the journal of the Association of European Psychiatrists, 2017, Volume: 42 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Databases, Factual; Drug Prescriptions; Female; Humans; Male; Methylphenidate; Research Design; Slovenia	2017
Patient and provider characteristics related with prescribing of ADHD medication: Nationwide health insurance claims database study in Korea. Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists, 2018, Volume: 10, Issue:1 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Databases, Factual; Drug Prescriptions; Female; Humans; Insurance, Health; Male; Methylphenidate; Physicians; Prevalence; Psychiatry; Republic of Korea	2018
Individual Variability and Medications to Treat Attention-Deficit/Hyperactivity Disorder: The World According to the Caudate. Journal of the American Academy of Child and Adolescent Psychiatry, 2017, Volume: 56, Issue:7 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Corpus Striatum; Humans; Methylphenidate	2017
Blockade of α2-adrenergic receptors in prelimbic cortex: impact on cocaine self-administration in adult spontaneously hypertensive rats following adolescent atomoxetine treatment. Psychopharmacology, 2017, Volume: 234, Issue:19 Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic Uptake Inhibitors; Age Factors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Cocaine; Cocaine-Related Disorders; Male; Methylphenidate; Prefrontal Cortex; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Self Administration; Species Specificity	2017
Methylphenidate and Atomoxetine-Responsive Prefrontal Cortical Genetic Overlaps in "Impulsive" SHR/NCrl and Wistar Rats. Behavior genetics, 2017, Volume: 47, Issue:5 Topics: Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Choice Behavior; Disease Models, Animal; Impulsive Behavior; Male; Methylphenidate; Prefrontal Cortex; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar	2017
Pharmacotherapy of Attention Deficit Hyperactivity Disorder Symptom Profile in ASD. The Journal of nervous and mental disease, 2017, Volume: 205, Issue:9 Topics: Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Comorbidity; Cross-Sectional Studies; Guanfacine; Humans; Methylphenidate; Randomized Controlled Trials as Topic; Risperidone; Social Adjustment; Treatment Outcome	2017
Placental Complications Associated With Psychostimulant Use in Pregnancy. Obstetrics and gynecology, 2017, Volume: 130, Issue:6 Topics: Abruptio Placentae; Adrenergic Uptake Inhibitors; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cohort Studies; Female; Fetal Growth Retardation; Humans; Methylphenidate; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimesters; Premature Birth; Risk Assessment; Statistics as Topic	2017
Shati/Nat8l knockout mice show behavioral deficits ameliorated by atomoxetine and methylphenidate. Behavioural brain research, 2018, Feb-26, Volume: 339 Topics: Acetyltransferases; Amphetamine-Related Disorders; Animals; Aspartic Acid; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Central Nervous System Stimulants; Methylphenidate; Mice, Knockout; Motor Activity	2018
Profiling attention and cognition enhancing drugs in a rat touchscreen-based continuous performance test. Psychopharmacology, 2018, Volume: 235, Issue:4 Topics: Animals; Atomoxetine Hydrochloride; Attention; Azetidines; Central Nervous System Stimulants; Cognition; Dose-Response Relationship, Drug; Impulsive Behavior; Male; Methylphenidate; Nootropic Agents; Photic Stimulation; Psychomotor Performance; Pyridines; Rats; Reaction Time; Touch	2018
Attention deficit hyperactivity disorder pharmacotherapy in Slovenian adults: a population-based study. International journal of clinical pharmacy, 2018, Volume: 40, Issue:2 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Databases, Factual; Female; Humans; Male; Methylphenidate; Middle Aged; Population Surveillance; Slovenia; Young Adult	2018
Systemic administration of guanfacine improves food-motivated impulsive choice behavior primarily via direct stimulation of postsynaptic α Behavioural brain research, 2018, 06-01, Volume: 345 Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Atomoxetine Hydrochloride; Choice Behavior; Dose-Response Relationship, Drug; Feeding Behavior; Food; Guanfacine; Impulsive Behavior; Male; Methylphenidate; Motivation; Neurons; Random Allocation; Rats, Wistar; Receptors, Adrenergic, alpha-2	2018
Risk of suicide attempts in adolescents and young adults with attention-deficit hyperactivity disorder: a nationwide longitudinal study. The British journal of psychiatry : the journal of mental science, 2018, Volume: 212, Issue:4 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Female; Humans; Longitudinal Studies; Male; Methylphenidate; National Health Programs; Risk Factors; Suicide, Attempted; Taiwan; Young Adult	2018
Semi-Automated Biomarker Discovery from Pharmacodynamic Effects on EEG in ADHD Rodent Models. Scientific reports, 2018, 03-26, Volume: 8, Issue:1 Topics: Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Biomarkers; Disease Models, Animal; Electroencephalography; Humans; Linear Models; Methylphenidate; Rats; Rats, Inbred SHR	2018
Pediatric ADHD Medication Exposures Reported to US Poison Control Centers. Pediatrics, 2018, Volume: 141, Issue:6 Topics: Adolescent; Age Distribution; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Drug Misuse; Humans; Infant; Infant, Newborn; Medication Errors; Methylphenidate; Modafinil; Patient Admission; Poison Control Centers; Retrospective Studies; Suicide, Attempted; United States; Young Adult	2018
Prevalence, incidence and persistence of ADHD drug use in Japan. Epidemiology and psychiatric sciences, 2019, Volume: 28, Issue:6 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Cohort Studies; Drug Prescriptions; Female; Humans; Incidence; Infant; Infant, Newborn; Japan; Male; Methylphenidate; Practice Patterns, Physicians'; Prevalence; Psychotropic Drugs; Retrospective Studies; Young Adult	2019
Therapy for fatigue and cognitive dysfunction in postural orthostatic tachycardia syndrome. Cardiology in the young, 2018, Volume: 28, Issue:12 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Central Nervous System Stimulants; Child; Cognitive Dysfunction; Databases, Factual; Drug Therapy, Combination; Drug Utilization; Fatigue; Female; Hospitals, Pediatric; Humans; Male; Methylphenidate; Philadelphia; Postural Orthostatic Tachycardia Syndrome; Retrospective Studies; Treatment Outcome	2018
Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases. The lancet. Psychiatry, 2018, Volume: 5, Issue:10 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Asia; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Australia; Central Nervous System Stimulants; Child; Child, Preschool; Europe; Female; Humans; Male; Methylphenidate; Middle Aged; Practice Patterns, Physicians'; Prevalence; Retrospective Studies; United States; Young Adult	2018
Effect of ADHD medication in male C57BL/6J mice performing the rodent Continuous Performance Test. Psychopharmacology, 2019, Volume: 236, Issue:6 Topics: Amphetamine; Animals; Atomoxetine Hydrochloride; Attention; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Impulsive Behavior; Male; Methylphenidate; Mice; Mice, Inbred C57BL; Neuropsychological Tests; Rodentia	2019
Incidence and risk of attention-deficit hyperactivity disorder in children with amblyopia: A nationwide cohort study. Clinical & experimental ophthalmology, 2019, Volume: 47, Issue:2 Topics: Adrenergic Uptake Inhibitors; Amblyopia; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Cohort Studies; Databases, Factual; Dopamine Uptake Inhibitors; Female; Humans; Incidence; Male; Methylphenidate; National Health Programs; Risk Factors; Taiwan; Visual Acuity	2019
Differential effects of ADHD medications on impulsive action in the mouse 5-choice serial reaction time task. European journal of pharmacology, 2019, Mar-15, Volume: 847 Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Choice Behavior; Impulsive Behavior; Male; Methylphenidate; Mice; Mice, Inbred C57BL; Reaction Time	2019
[Treatment of attention-deficit/hyperactivity disorder in clinical practice. A retrospective study]. Medicina, 2019, Volume: 79, Issue:Suppl 1 Topics: Adolescent; Adrenergic Uptake Inhibitors; Age Distribution; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Female; Humans; Male; Methylphenidate; Patient Dropouts; Psychotherapy; Retrospective Studies; Sex Distribution	2019
Effects of amphetamine, methylphenidate, atomoxetine, and morphine in rats responding under an adjusting stop signal reaction time task. Psychopharmacology, 2019, Volume: 236, Issue:6 Topics: Amphetamine; Analgesics, Opioid; Animals; Atomoxetine Hydrochloride; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Impulsive Behavior; Male; Methylphenidate; Morphine; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Reaction Time	2019
Drug Prescriptions for Children With ADHD in Japan: A Study Based on Health Insurance Claims Data Between 2005 and 2015. Journal of attention disorders, 2020, Volume: 24, Issue:2 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Drug Prescriptions; Humans; Insurance, Health; Japan; Methylphenidate	2020
Consumption of methylphenidate and atomoxetine in the private healthcare sector in South Africa: a longitudinal study. International journal of clinical pharmacy, 2019, Volume: 41, Issue:4 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Databases, Factual; Drug Utilization; Female; Health Care Sector; Humans; Longitudinal Studies; Male; Methylphenidate; Practice Patterns, Physicians'; Private Sector; South Africa	2019
ADHD medication and the inverted U-shaped curve: A pharmacological study in female mice performing the rodent Continuous Performance Test (rCPT). Progress in neuro-psychopharmacology & biological psychiatry, 2020, 04-20, Volume: 99 Topics: Amphetamine; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Discrimination Learning; Female; Methylphenidate; Mice; Mice, Inbred C57BL; Psychomotor Performance; Rodentia	2020
Atomoxetine Reestablishes Long Term Potentiation in a Mouse Model of Attention Deficit/Hyperactivity Disorder. Neuroscience, 2020, 07-15, Volume: 439 Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Long-Term Potentiation; Methylphenidate; Mice; Treatment Outcome	2020
Patterns of long-term ADHD medication use in Australian children. Archives of disease in childhood, 2020, Volume: 105, Issue:6 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Australia; Central Nervous System Stimulants; Child; Child, Preschool; Dextroamphetamine; Drug Prescriptions; Female; Humans; Longitudinal Studies; Male; Medication Adherence; Methylphenidate; Sex Distribution; Social Class	2020
Amphetamine promotes cortical Up state: Role of adrenergic receptors. Addiction biology, 2021, Volume: 26, Issue:1 Topics: Amphetamine; Animals; Atomoxetine Hydrochloride; Dextroamphetamine; Dopamine; Male; Methylphenidate; Neurons; Norepinephrine; Prazosin; Prefrontal Cortex; Rats; Receptors, Adrenergic	2021
Sleep habits of children diagnosed with attention/ deficit/ hyperactivity disorder and effects of treatment on sleep related parameters. Asian journal of psychiatry, 2020, Volume: 52 Topics: Adolescent; Atomoxetine Hydrochloride; Attention; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Humans; Methylphenidate; Sleep; Treatment Outcome	2020
Different effects of methylphenidate and atomoxetine on the behavior and brain transcriptome of zebrafish. Molecular brain, 2020, 05-06, Volume: 13, Issue:1 Topics: Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior Rating Scale; Brain; Gene Ontology; Lipid Metabolism; Methylphenidate; Signal Transduction; Transcriptome; Zebrafish	2020
The effects of medication on intraocular pressure in children with attention deficit hyperactivity disorder: A prospective study. Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique, 2020, 05-01, Volume: 27, Issue:2 Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Female; Humans; Intraocular Pressure; Male; Manometry; Methylphenidate; Prospective Studies; Time Factors	2020
The 10-year trend in drug prescriptions for attention-deficit/hyperactivity disorder (ADHD) in Germany. European journal of clinical pharmacology, 2021, Volume: 77, Issue:1 Topics: Adolescent; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Dextroamphetamine; Drug Prescriptions; Female; Germany; Guanfacine; Humans; Male; Methylphenidate; Practice Patterns, Physicians'; Young Adult	2021
Medication utilization among adult patients with attention-deficit/hyperactivity disorder after reimbursement criteria change. International clinical psychopharmacology, 2020, Volume: 35, Issue:6 Topics: Adolescent; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Drug Prescriptions; Female; Humans; Male; Methylphenidate	2020
Adult attention deficit/hyperactivity disorder in the ambulatory care setting: Erratum. JAAPA : official journal of the American Academy of Physician Assistants, 2020, Volume: 33, Issue:11 Topics: Ambulatory Care; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Contraindications, Drug; Dopamine; Feeding and Eating Disorders; Humans; Methylphenidate; Norepinephrine	2020
Commentary: Identifying individualized predictions of response in ADHD pharmacotherapy - a commentary on Rodrigues et al. (2020). Journal of child psychology and psychiatry, and allied disciplines, 2021, Volume: 62, Issue:6 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Guanfacine; Humans; Methylphenidate	2021
Drug prescription for attention deficit hyperactivity disorder drugs in pediatric outpatients: A retrospective survey of Japanese administrative data (2012-2018). Asian journal of psychiatry, 2021, Volume: 57 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Drug Prescriptions; Female; Humans; Japan; Male; Methylphenidate; Outpatients; Pharmaceutical Preparations; Retrospective Studies	2021
Treatment of attention deficit/hyperactivity disorder in children with CHD. Cardiology in the young, 2021, Volume: 31, Issue:6 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Humans; Methylphenidate; Retrospective Studies	2021
Synergistic efficacy and diminished adverse effect profile of composite treatment of several ADHD medications. Neuropharmacology, 2021, 04-01, Volume: 187 Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Disease Models, Animal; Dizocilpine Maleate; Dopamine Uptake Inhibitors; Drug Synergism; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Fluoxetine; Growth and Development; Methylphenidate; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Open Field Test; Proto-Oncogene Proteins c-akt; Selective Serotonin Reuptake Inhibitors; Sleep	2021
Current use of attention-deficit hyperactivity disorder (ADHD) medications and clinical characteristics of child and adolescent psychiatric outpatients prescribed multiple ADHD medications in Japan. PloS one, 2021, Volume: 16, Issue:6 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Female; Guanfacine; Humans; Japan; Logistic Models; Male; Methylphenidate; Outpatients; Prospective Studies; Retrospective Studies	2021
Medications for attention-deficit/hyperactivity disorder in Japan: A retrospective cohort study of label compliance. Neuropsychopharmacology reports, 2021, Volume: 41, Issue:3 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Humans; Japan; Male; Methylphenidate; Pharmaceutical Preparations; Retrospective Studies	2021
Methylphenidate and atomoxetine treatment negatively affect physical growth indexes of school-age children and adolescents with attention-deficit/hyperactivity disorder. Pharmacology, biochemistry, and behavior, 2021, Volume: 208 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Body Height; Body Mass Index; Body Weight; Central Nervous System Stimulants; Child; China; Female; Humans; Male; Methylphenidate; Schools; Time Factors	2021
Secular trends and regional variations in pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) among children and adolescents in Germany. BMC psychiatry, 2021, 08-14, Volume: 21, Issue:1 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Germany; Humans; Methylphenidate	2021
Descriptive analysis of adverse drug reaction reports in children and adolescents from Germany: frequently reported reactions and suspected drugs. BMC pharmacology & toxicology, 2021, 10-07, Volume: 22, Issue:1 Topics: Adolescent; Atomoxetine Hydrochloride; Child; Child, Preschool; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Etanercept; Female; Germany; Humans; Ibuprofen; Infant; Infant, Newborn; Male; Methylphenidate; Off-Label Use; Palivizumab; Pharmacovigilance	2021
Brainmarker-I Differentially Predicts Remission to Various Attention-Deficit/Hyperactivity Disorder Treatments: A Discovery, Transfer, and Blinded Validation Study. Biological psychiatry. Cognitive neuroscience and neuroimaging, 2023, Volume: 8, Issue:1 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Humans; Male; Methylphenidate; Retrospective Studies; Treatment Outcome	2023
Shared and Unique Effects of Long-Term Administration of Methylphenidate and Atomoxetine on Degree Centrality in Medication-Naïve Children With Attention-Deficit/Hyperactive Disorder. The international journal of neuropsychopharmacology, 2022, 09-28, Volume: 25, Issue:9 Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain; Central Nervous System Stimulants; Child; Humans; Methylphenidate	2022
The Effects of Drug Treatments for ADHD in Measures of Cognitive Performance. Current topics in behavioral neurosciences, 2022, Volume: 57 Topics: Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cognition; Humans; Methylphenidate; Propylamines	2022
Trends in use of attention deficit hyperactivity disorder medication among children and adolescents in Scandinavia in 2010-2020. European child & adolescent psychiatry, 2023, Volume: 32, Issue:10 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Female; Humans; Male; Methylphenidate; Scandinavian and Nordic Countries	2023
The Pharmacogenetic Impact on the Pharmacokinetics of ADHD Medications. Methods in molecular biology (Clifton, N.J.), 2022, Volume: 2547 Topics: Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Cytochrome P-450 CYP2D6; Humans; Methylphenidate; Pharmacogenetics	2022
Psychostimulants Modafinil, Atomoxetine and Guanfacine Impair Bone Cell Differentiation and MSC Migration. International journal of molecular sciences, 2022, Sep-06, Volume: 23, Issue:18 Topics: Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Cell Differentiation; Central Nervous System Stimulants; Child; Guanfacine; Humans; Ligands; Methylphenidate; Modafinil; Nootropic Agents; Osteoprotegerin; Receptor Activator of Nuclear Factor-kappa B	2022
Post-treatment symptomatic improvement of the eastern Indian ADHD probands is influenced by Drug metabolism and personalized therapy, 2023, 03-01, Volume: 38, Issue:1 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Cytochrome P-450 CYP2D6; Genetic Variation; Humans; Male; Methylphenidate; Treatment Outcome	2023
Novel non-stimulants rescue hyperactive phenotype in an adgrl3.1 mutant zebrafish model of ADHD. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2023, Volume: 48, Issue:8 Topics: Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Imidazolines; Methylphenidate; Mice; Phenotype; Zebrafish	2023
Theory of visual attention (TVA) applied to rats performing the 5-choice serial reaction time task: differential effects of dopaminergic and noradrenergic manipulations. Psychopharmacology, 2023, Volume: 240, Issue:1 Topics: Amphetamine; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dopamine; Humans; Methylphenidate; Norepinephrine; Phenylephrine; Rats; Reaction Time	2023
Prevalence trends and individual patterns of ADHD medication use in pregnancy in Norway and Sweden, 2010-2019. European journal of clinical pharmacology, 2023, Volume: 79, Issue:1 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Female; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Norway; Pregnancy; Prevalence; Sweden	2023
Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction of CYP2D6 and COMT with atomoxetine and methylphenidate. European journal of human genetics : EJHG, 2023, Volume: 31, Issue:12 Topics: Atomoxetine Hydrochloride; Catechol O-Methyltransferase; Clonidine; Cytochrome P-450 CYP2D6; Drug Interactions; Humans; Methylphenidate; Pharmacogenetics	2023
Effect of atomoxetine on ADHD-pain hypersensitization comorbidity in 6-OHDA lesioned mice. Pharmacological reports : PR, 2023, Volume: 75, Issue:2 Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Comorbidity; Male; Methylphenidate; Mice; Oxidopamine; Pain; Propylamines	2023
Prescribing patterns for attention deficit hyperactivity disorder among children and adolescents in Taiwan from 2004 to 2017. Journal of the Formosan Medical Association = Taiwan yi zhi, 2023, Volume: 122, Issue:6 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Humans; Methylphenidate; Taiwan	2023
Pharmacologic Management of Cognitive Disengagement Syndrome (CDS) and Implications for Attention-Deficit/Hyperactivity Disorder (ADHD) Treatment: Emerging Treatments and Recommendations for Future Research. CNS drugs, 2023, Volume: 37, Issue:4 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cognition; Humans; Lisdexamfetamine Dimesylate; Methylphenidate	2023